Form 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 27, 2009
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission file number 1-5353
TELEFLEX INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
|
|
23-1147939
(I.R.S. employer identification no.) |
incorporation or organization) |
|
|
|
|
|
155 South Limerick Road, Limerick, Pennsylvania
|
|
19468 |
(Address of principal executive offices)
|
|
(Zip Code) |
(610) 948-5100
(Registrants telephone number, including area code)
(None)
(Former Name, Former Address and Former Fiscal Year,
If Changed Since Last Report)
Indicate by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filler, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Act). Yes o No þ
On October 16, 2009, 39,727,071 shares of the registrants common stock, $1.00 par value, were
outstanding.
TELEFLEX INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 27, 2009
TABLE OF CONTENTS
1
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars and shares in thousands, except per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenues |
|
$ |
461,479 |
|
|
$ |
504,035 |
|
|
$ |
1,375,059 |
|
|
$ |
1,569,486 |
|
Materials, labor and other product costs |
|
|
260,925 |
|
|
|
294,202 |
|
|
|
780,710 |
|
|
|
917,802 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
200,554 |
|
|
|
209,833 |
|
|
|
594,349 |
|
|
|
651,684 |
|
Selling, engineering and administrative expenses |
|
|
126,151 |
|
|
|
137,527 |
|
|
|
381,132 |
|
|
|
432,833 |
|
Net loss on sales of businesses and
assets |
|
|
|
|
|
|
|
|
|
|
2,597 |
|
|
|
18 |
|
Goodwill impairment |
|
|
|
|
|
|
|
|
|
|
6,728 |
|
|
|
|
|
Restructuring and other impairment charges |
|
|
4,783 |
|
|
|
470 |
|
|
|
13,412 |
|
|
|
11,917 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before interest and
taxes |
|
|
69,620 |
|
|
|
71,836 |
|
|
|
190,480 |
|
|
|
206,916 |
|
Interest expense |
|
|
21,074 |
|
|
|
28,983 |
|
|
|
68,470 |
|
|
|
91,433 |
|
Interest income |
|
|
(233 |
) |
|
|
(492 |
) |
|
|
(1,907 |
) |
|
|
(1,861 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes |
|
|
48,779 |
|
|
|
43,345 |
|
|
|
123,917 |
|
|
|
117,344 |
|
Taxes on income from continuing operations |
|
|
13,740 |
|
|
|
13,718 |
|
|
|
29,262 |
|
|
|
39,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
35,039 |
|
|
|
29,627 |
|
|
|
94,655 |
|
|
|
77,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income from discontinued operations
(including (loss) gain on disposal of ($3,480) and $272,307
for the three and nine month periods in 2009, respectively
and (loss) on disposal of ($4,808) for the nine month
period in 2008) |
|
|
(4,207 |
) |
|
|
22,302 |
|
|
|
269,222 |
|
|
|
47,850 |
|
Taxes (benefit) on income from discontinued
operations |
|
|
(7,785 |
) |
|
|
(17 |
) |
|
|
92,881 |
|
|
|
(233 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
3,578 |
|
|
|
22,319 |
|
|
|
176,341 |
|
|
|
48,083 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
38,617 |
|
|
|
51,946 |
|
|
|
270,996 |
|
|
|
125,984 |
|
Less: Net income attributable to noncontrolling
interest |
|
|
305 |
|
|
|
196 |
|
|
|
843 |
|
|
|
642 |
|
Income from discontinued operations attributable to
noncontrolling interest |
|
|
|
|
|
|
9,431 |
|
|
|
9,860 |
|
|
|
25,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common shareholders |
|
$ |
38,312 |
|
|
$ |
42,319 |
|
|
$ |
260,293 |
|
|
$ |
100,205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share available to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.87 |
|
|
$ |
0.74 |
|
|
$ |
2.36 |
|
|
$ |
1.95 |
|
Income from discontinued operations |
|
$ |
0.09 |
|
|
$ |
0.33 |
|
|
$ |
4.19 |
|
|
$ |
0.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.96 |
|
|
$ |
1.07 |
|
|
$ |
6.55 |
|
|
$ |
2.53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.87 |
|
|
$ |
0.74 |
|
|
$ |
2.35 |
|
|
$ |
1.94 |
|
Income from discontinued operations |
|
$ |
0.09 |
|
|
$ |
0.32 |
|
|
$ |
4.17 |
|
|
$ |
0.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.96 |
|
|
$ |
1.06 |
|
|
$ |
6.52 |
|
|
$ |
2.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per share |
|
$ |
0.34 |
|
|
$ |
0.34 |
|
|
$ |
1.02 |
|
|
$ |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
39,724 |
|
|
|
39,645 |
|
|
|
39,711 |
|
|
|
39,553 |
|
Diluted |
|
|
39,932 |
|
|
|
39,970 |
|
|
|
39,910 |
|
|
|
39,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations, net of
tax |
|
$ |
34,734 |
|
|
$ |
29,431 |
|
|
$ |
93,812 |
|
|
$ |
77,259 |
|
Income from discontinued operations, net of tax |
|
|
3,578 |
|
|
|
12,888 |
|
|
|
166,481 |
|
|
|
22,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
38,312 |
|
|
$ |
42,319 |
|
|
$ |
260,293 |
|
|
$ |
100,205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
2
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash
equivalents |
|
$ |
158,789 |
|
|
$ |
107,275 |
|
Accounts receivable,
net |
|
|
266,924 |
|
|
|
311,908 |
|
Inventories,
net |
|
|
395,234 |
|
|
|
424,653 |
|
Prepaid expenses and other current
assets |
|
|
20,099 |
|
|
|
21,373 |
|
Income taxes
receivable |
|
|
37,628 |
|
|
|
17,958 |
|
Deferred tax
assets |
|
|
58,609 |
|
|
|
66,009 |
|
Assets held for
sale |
|
|
9,010 |
|
|
|
8,210 |
|
|
|
|
|
|
|
|
Total current
assets |
|
|
946,293 |
|
|
|
957,386 |
|
Property, plant and equipment,
net |
|
|
327,014 |
|
|
|
374,292 |
|
Goodwill |
|
|
1,466,829 |
|
|
|
1,474,123 |
|
Intangibles and other assets,
net |
|
|
1,055,329 |
|
|
|
1,090,852 |
|
Investments in
affiliates |
|
|
12,214 |
|
|
|
28,105 |
|
Deferred tax
assets |
|
|
|
|
|
|
1,986 |
|
|
|
|
|
|
|
|
Total
assets |
|
$ |
3,807,679 |
|
|
$ |
3,926,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Current
borrowings |
|
$ |
5,956 |
|
|
$ |
108,853 |
|
Accounts
payable |
|
|
85,834 |
|
|
|
139,677 |
|
Accrued
expenses |
|
|
101,720 |
|
|
|
125,183 |
|
Payroll and benefit-related
liabilities |
|
|
72,544 |
|
|
|
83,129 |
|
Derivative
liabilities |
|
|
18,240 |
|
|
|
27,370 |
|
Accrued
interest |
|
|
19,950 |
|
|
|
26,888 |
|
Income taxes
payable |
|
|
13,341 |
|
|
|
12,613 |
|
Deferred tax
liabilities |
|
|
8,254 |
|
|
|
2,227 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
325,839 |
|
|
|
525,940 |
|
Long-term borrowings |
|
|
1,248,584 |
|
|
|
1,437,538 |
|
Deferred tax
liabilities |
|
|
344,197 |
|
|
|
324,678 |
|
Pension and postretirement benefit
liabilities |
|
|
169,868 |
|
|
|
169,841 |
|
Other
liabilities |
|
|
165,628 |
|
|
|
182,864 |
|
|
|
|
|
|
|
|
Total
liabilities |
|
|
2,254,116 |
|
|
|
2,640,861 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Total common shareholders
equity |
|
|
1,549,092 |
|
|
|
1,246,455 |
|
Noncontrolling
interest |
|
|
4,471 |
|
|
|
39,428 |
|
|
|
|
|
|
|
|
Total
equity |
|
|
1,553,563 |
|
|
|
1,285,883 |
|
|
|
|
|
|
|
|
Total liabilities and
equity |
|
$ |
3,807,679 |
|
|
$ |
3,926,744 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
3
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Cash Flows from Operating Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
270,996 |
|
|
$ |
125,984 |
|
Adjustments to reconcile net income to net cash provided by operating
activities: |
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
(176,341 |
) |
|
|
(48,083 |
) |
Depreciation expense |
|
|
42,599 |
|
|
|
44,065 |
|
Amortization expense of intangible assets |
|
|
32,917 |
|
|
|
34,255 |
|
Amortization expense of deferred financing costs |
|
|
4,556 |
|
|
|
3,931 |
|
Impairment of long-lived assets |
|
|
5,788 |
|
|
|
|
|
Impairment of goodwill |
|
|
6,728 |
|
|
|
|
|
Stock-based compensation |
|
|
6,793 |
|
|
|
6,447 |
|
Net loss on sales of businesses and assets |
|
|
2,597 |
|
|
|
18 |
|
Other |
|
|
257 |
|
|
|
16,901 |
|
Changes in operating assets and liabilities, net of effects of acquisitions
and
disposals: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
12,491 |
|
|
|
(7,081 |
) |
Inventories |
|
|
7,455 |
|
|
|
(9,838 |
) |
Prepaid expenses and other current assets |
|
|
2,274 |
|
|
|
9,104 |
|
Accounts payable and accrued expenses |
|
|
(45,493 |
) |
|
|
8,032 |
|
Income taxes payable and deferred income taxes |
|
|
(92,396 |
) |
|
|
(135,591 |
) |
|
|
|
|
|
|
|
Net cash provided by operating activities from continuing operations |
|
|
81,221 |
|
|
|
48,144 |
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Proceeds from long-term borrowings |
|
|
10,018 |
|
|
|
77,000 |
|
Reduction in long-term borrowings |
|
|
(300,268 |
) |
|
|
(185,345 |
) |
(Decrease) increase in notes payable and current borrowings |
|
|
(836 |
) |
|
|
2,386 |
|
Proceeds from stock compensation plans |
|
|
750 |
|
|
|
7,717 |
|
Payments to noncontrolling interest shareholders |
|
|
(702 |
) |
|
|
(739 |
) |
Dividends |
|
|
(40,521 |
) |
|
|
(39,568 |
) |
|
|
|
|
|
|
|
Net cash used in financing activities from continuing
operations |
|
|
(331,559 |
) |
|
|
(138,549 |
) |
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Expenditures for property, plant and equipment |
|
|
(21,485 |
) |
|
|
(25,546 |
) |
Proceeds from sales of businesses and assets, net of cash sold |
|
|
314,513 |
|
|
|
6,681 |
|
Payments for businesses and intangibles acquired, net of cash acquired |
|
|
(1,730 |
) |
|
|
(6,083 |
) |
Investments in affiliates |
|
|
|
|
|
|
(320 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities from continuing operations |
|
|
291,298 |
|
|
|
(25,268 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Discontinued Operations: |
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
14,358 |
|
|
|
44,388 |
|
Net cash used in financing activities |
|
|
(11,075 |
) |
|
|
(32,340 |
) |
Net cash used in investing activities |
|
|
(1,173 |
) |
|
|
(2,746 |
) |
|
|
|
|
|
|
|
Net cash provided by discontinued operations |
|
|
2,110 |
|
|
|
9,302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
8,444 |
|
|
|
(3,574 |
) |
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
51,514 |
|
|
|
(109,945 |
) |
Cash and cash equivalents at the beginning of the period |
|
|
107,275 |
|
|
|
201,342 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the period |
|
$ |
158,789 |
|
|
$ |
91,397 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
4
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
Other |
|
|
Treasury |
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Paid in |
|
|
Retained |
|
|
Comprehensive |
|
|
Stock |
|
|
Noncontrolling |
|
|
Total |
|
|
Comprehensive |
|
|
|
Shares |
|
|
Dollars |
|
|
Capital |
|
|
Earnings |
|
|
Income |
|
|
Shares |
|
|
Dollars |
|
|
Interest |
|
|
Equity |
|
|
Income |
|
|
|
(Dollars and shares in thousands, except per share) |
|
Balance at December 31, 2007 |
|
|
41,794 |
|
|
$ |
41,794 |
|
|
$ |
252,108 |
|
|
$ |
1,118,053 |
|
|
$ |
56,919 |
|
|
|
2,343 |
|
|
$ |
(140,031 |
) |
|
$ |
42,183 |
|
|
$ |
1,371,026 |
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,779 |
|
|
|
125,984 |
|
|
$ |
125,984 |
|
Split-dollar life insurance arrangements adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,874 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,874 |
) |
|
|
(1,874 |
) |
Cash dividends ($1.00 per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(39,568 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(39,568 |
) |
|
|
|
|
Financial instruments marked to market, net of tax of $(48) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(64 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(64 |
) |
|
|
(64 |
) |
Cumulative translation adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,126 |
) |
|
|
|
|
|
|
|
|
|
|
(279 |
) |
|
|
(14,405 |
) |
|
|
(14,405 |
) |
Pension liability adjustment, net of tax of $3,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,399 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,399 |
) |
|
|
(2,399 |
) |
Distributions to noncontrolling interest shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(33,079 |
) |
|
|
(33,079 |
) |
|
|
|
|
Disposition of noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
804 |
|
|
|
804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
107,242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under compensation plans |
|
|
190 |
|
|
|
190 |
|
|
|
14,423 |
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
|
|
657 |
|
|
|
|
|
|
|
15,270 |
|
|
|
|
|
Deferred compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8 |
) |
|
|
332 |
|
|
|
|
|
|
|
332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at September 28, 2008 |
|
|
41,984 |
|
|
$ |
41,984 |
|
|
$ |
266,531 |
|
|
$ |
1,176,816 |
|
|
$ |
40,330 |
|
|
|
2,320 |
|
|
$ |
(139,042 |
) |
|
$ |
35,408 |
|
|
$ |
1,422,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008 |
|
|
41,995 |
|
|
$ |
41,995 |
|
|
$ |
268,263 |
|
|
$ |
1,182,906 |
|
|
$ |
(108,202 |
) |
|
|
2,311 |
|
|
$ |
(138,507 |
) |
|
$ |
39,428 |
|
|
$ |
1,285,883 |
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
260,293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,703 |
|
|
|
270,996 |
|
|
$ |
270,996 |
|
Cash dividends ($1.02 per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40,521 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40,521 |
) |
|
|
|
|
Financial instruments marked to market, net of tax of $6,005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,858 |
|
|
|
13,858 |
|
Cumulative translation adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,658 |
|
|
|
|
|
|
|
|
|
|
|
61 |
|
|
|
60,719 |
|
|
|
60,719 |
|
Pension
liability adjustment, net of tax of $1,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
764 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
764 |
|
|
|
764 |
|
Distributions to noncontrolling interest shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(702 |
) |
|
|
(702 |
) |
|
|
|
|
Disposition of noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(45,019 |
) |
|
|
(45,019 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
346,337 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under compensation plans |
|
|
20 |
|
|
|
20 |
|
|
|
6,261 |
|
|
|
|
|
|
|
|
|
|
|
(14 |
) |
|
|
961 |
|
|
|
|
|
|
|
7,242 |
|
|
|
|
|
Deferred compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9 |
) |
|
|
343 |
|
|
|
|
|
|
|
343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at September 27, 2009 |
|
|
42,015 |
|
|
$ |
42,015 |
|
|
$ |
274,524 |
|
|
$ |
1,402,678 |
|
|
$ |
(32,922 |
) |
|
|
2,288 |
|
|
$ |
(137,203 |
) |
|
$ |
4,471 |
|
|
$ |
1,553,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 Basis of presentation
We prepared the accompanying unaudited condensed consolidated financial statements of Teleflex
Incorporated on the same basis as our annual consolidated financial statements, with the exception
of changes resulting from the adoption of new accounting guidance during the first nine months of
2009 as described in Note 2 below. As a result of this new accounting guidance, we reclassified
certain prior year amounts.
In the opinion of management, our financial statements reflect all adjustments, which are of a
normal recurring nature, necessary for a fair presentation of financial statements for interim
periods in accordance with U.S. generally accepted accounting principles (GAAP) and with Rule 10-01
of SEC Regulation S-X, which sets forth the instructions for financial statements included in Form
10-Q. The preparation of consolidated financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of our financial
statements, as well as the reported amounts of revenue and expenses during the reporting periods.
Actual results could differ from those estimates.
We have evaluated the period from September 27, 2009, the date of the financial statements,
through October 27, 2009, the date of the issuance and filing of the financial statements, and
determined that no material subsequent events occurred that would affect the information presented
in these financial statements or require additional disclosure.
In accordance with applicable accounting standards, the accompanying condensed financial
statements do not include all of the information and footnote disclosures that are required to be
included in our annual consolidated financial statements. The year-end condensed balance sheet data
was derived from audited financial statements, but does not include all disclosures required by
GAAP. Accordingly, our quarterly condensed financial statements should be read in conjunction with
the consolidated financial statements included in our Annual Report on Form 10-K for the year ended
December 31, 2008.
As used in this report, the terms we, us, our, Teleflex and the Company mean
Teleflex Incorporated and its subsidiaries, unless the context indicates otherwise. The results of
operations for the periods reported are not necessarily indicative of those that may be expected
for a full year.
Note 2 New accounting standards
The financial statements included in this report reflect changes resulting from the recent
adoption of several accounting pronouncements. The subject matter of the changes, and the footnotes
in which they appear, are as follows:
Evaluation period of subsequent events in Note 1;
Disclosure of derivative instruments and hedging activities in Note 8;
Fair value of long-term debt in Note 9; and
Fair value measurements in Note 9.
Described below are several accounting pronouncements that we either recently adopted
(including those reflected in the footnotes referenced above) or will adopt in the near future:
The Company adopted the following new accounting standards as of January 1, 2009, the first
day of its 2009 fiscal year:
Fair Value Measurements: In September 2006, the Financial Accounting Standards Board
(FASB) issued Accounting Standards Codification (ASC) topic 820, Fair Value Measurements
and Disclosures. This topic established a common definition of fair value, established a
framework for measuring fair value, and expanded disclosure about such fair value
measurements.
In February 2008, the FASB updated Fair Value Measurements and Disclosures allowing a
deferral of the effective date of this topic for all nonfinancial assets and nonfinancial
liabilities, except those that are recognized or disclosed at fair value in the financial
statements on a recurring basis (at least annually). The Company adopted the initial topic as
of January 1, 2008 with respect to financial assets and financial liabilities and adopted the
update to the topic as of January 1, 2009 with respect to nonfinancial assets and
liabilities. While the topic and the related update did not have a material impact on the
Companys results of operations, cash flows or financial position upon adoption, the topic
required additional disclosures regarding the Companys assets and liabilities recorded at
fair value which disclosures are included in Note 9.
6
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Business Combinations: In December 2007, the FASB revised the accounting for business
combinations (ASC topic 805, Business Combinations). The revised topic
retained the fundamental requirement that the acquisition method of accounting (previously
referred to as the purchase method) be used for all business combinations and that an
acquirer be identified for each business combination. The revised topic defines the acquirer
as the entity that obtains control of one or more businesses in the business combination and
establishes the acquisition date as the date that the acquirer achieves control.
The revised topic replaces the cost-allocation process and requires an acquirer to
recognize the assets acquired, the liabilities assumed, and any non-controlling interest in
the acquired business at the acquisition date, measured at their fair values as of that date,
with limited exceptions. In addition, the revised topic changes the allocation and treatment
of acquisition-related costs, restructuring costs that the acquirer expected but was not
obligated to incur, the recognition of assets acquired and liabilities assumed arising from
contingencies and the recognition and measurement of goodwill.
The
FASB issued an update to amend the Business Combinations topic on April 1, 2009. The
amendment clarified issues that arose regarding initial recognition and measurement,
subsequent measurement and accounting and disclosure of assets and liabilities arising from
contingencies in a business combination.
The revised topic and the related update did not have an impact on the Companys results
of operations, cash flows or financial position upon their adoption.
Non-controlling Interests: In December 2007, the FASB issued an update to ASC topic 810,
Consolidation. The update establishes accounting and reporting standards for the
non-controlling interest in a subsidiary, sometimes referred to as minority interest, and for
the deconsolidation of a subsidiary. The update clarifies that a non-controlling interest in
a subsidiary is an ownership interest in the consolidated entity that should be reported as
equity in the consolidated financial statements. The update requires that a non-controlling
interest in subsidiaries held by parties other than the parent be clearly identified,
labeled, and presented in the consolidated statement of financial position within equity, but
separate from the parents equity, that the amount of consolidated net income attributable to
the parent and to the non-controlling interest be clearly identified and presented on the
face of the consolidated statement of income, that the changes in a parents ownership
interest while the parent retains its controlling financial interest in its subsidiary be
accounted for consistently as equity transactions and that when a subsidiary is
deconsolidated, any retained non-controlling equity investment in the former subsidiary be
initially measured at fair value. The adoption changed the presentation of non-controlling
interests on our income statement, balance sheet and changes in shareholders equity.
Disclosures about derivative instruments and hedging activities: In March 2008, the
FASB issued an update to ASC topic 815, Derivatives and Hedging, which requires enhanced
disclosures about (a) how and why a company uses derivative instruments, (b) how derivative
instruments and related hedged items are accounted for under the topic and related
interpretations, and (c) how derivative instruments and related hedged items affect the
Companys financial position, financial performance, and cash flows. Refer to Note 8 for the
enhanced disclosures related to the Companys derivative instruments.
Determination of the Useful Life of Intangible Assets: In April 2008, the FASB
issued an amendment to ASC topic 350, Intangibles-Goodwill and Other, that addresses the
factors that should be considered in developing renewal or extension assumptions used to
determine the useful lives for intangible assets. The amendment requires an entity to
consider its own historical experience in renewing or extending similar arrangements,
regardless of whether those arrangements have explicit renewal or extension provisions, when
determining the useful life of an intangible asset. In the absence of such experience, an
entity shall consider the assumptions that market participants would use about renewal or
extension, adjusted for entity-specific factors. The amendment did not have a material impact
on the Companys results of operations, cash flows or financial position upon adoption.
The Company adopted the following new accounting standards in the second quarter of 2009:
Interim Disclosures about Fair Value of Financial Instruments: In April 2009, the FASB
issued an update to ASC topic 470, Debt, which requires disclosures about fair value of
financial instruments for interim reporting periods as well as in annual financial
statements. The update also amends prior guidance under ASC topic 270, Interim Reporting,
to require those disclosures in summarized financial information at interim reporting
periods. The update requires that an entity disclose in the body or in the accompanying notes
of its financial information the fair value of all financial instruments for which it is
practicable to estimate that value, whether recognized or not recognized in the statement of
financial position. In addition, an entity shall also disclose the method(s) and significant
assumptions used to estimate the fair value of financial instruments.
7
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The update does not require disclosures for earlier periods presented for comparative
purposes at initial adoption. Refer to Note 9 for the interim fair value disclosures related
to the Companys financial instruments.
Determining Fair Value When the Volume and Level of Activity for the Asset or Liability
Have Significantly Decreased and Identifying Transactions That Are Not Orderly: In April
2009, the FASB issued an update to ASC topic 820, Fair Value Measurements and Disclosures,
that provides additional guidance for estimating fair value when the volume and level of
activity for the asset or liability have significantly decreased. The update also includes
guidance on identifying circumstances that indicate a transaction is not orderly.
The update does not require disclosures for earlier periods presented for comparative
purposes at initial adoption. The adoption of the update did not have a material impact on
the Companys results of operations, cash flows or financial position.
Subsequent Events: In May 2009, the FASB issued ASC topic 855, Subsequent Events,
which establishes reporting and disclosure requirements based on the existence of conditions
at the date of the balance sheet for events or transactions that occurred after the balance
sheet date but before the financial statements are issued or are available to be issued.
Companies are required to disclose the date through which subsequent events have been
evaluated and whether that date is the date the financial statements were issued or were
available to be issued.
The Company adopted the following new accounting standard in the third quarter of 2009:
The FASB Accounting Standards CodificationTM and the Hierarchy of Generally
Accepted Accounting Principles: In June 2009, the FASB issued an amendment to ASC topic 105,
Generally Accepted Accounting Principles. The amendment identifies the sources of
accounting principles and the framework for selecting the principles used in the preparation
of financial statements of nongovernmental entities that are presented in conformity with
GAAP in the United States (the GAAP hierarchy). The amendment establishes the Codification as
the source of authoritative GAAP recognized by the FASB to be applied by nongovernmental
entities. Rules and interpretive releases of the SEC under federal securities laws are also
sources of authoritative GAAP for SEC registrants. All guidance contained in the Codification
carries an equal level of authority.
The Company will adopt the following new accounting standards in the fourth quarter of 2009:
Employers Disclosures about Postretirement Benefit Plan Assets: In December 2008, the
FASB issued an update to ASC topic 715, Compensation-Retirement Benefits, which requires
additional disclosures regarding employers pension and other postretirement benefit plan
assets. Disclosures regarding fair value measurements of pension and other postretirement
benefit plan assets previously were not included within the scope of the topic. The update
requires employers to disclose information about fair value measurements of plan assets that
would be similar to the disclosures about fair value measurements required under ASC topic
820, Fair Value Measurements and Disclosures, the investment policies and strategies for
the major categories of plan assets, and significant concentrations of risk within plan
assets. The update is effective for the Company as of December 31, 2009. Since the update
provides only disclosure requirements, the adoption will not have a material impact on the
Companys results of operations, cash flows or financial position.
Measuring Liabilities at Fair Value: In September 2009, the FASB issued an amendment to
ASC topic 820, Fair Value Measurements and Disclosures, to clarify how an entity should
measure the fair value of liabilities. The amendment also clarifies that restrictions which
prevent the transfer of a liability should not be considered as separate inputs or
adjustments in the measurement of the liabilitys fair value. The amendment reaffirms the
measurements concept of determining fair value based on an orderly transaction between market
participants even though liabilities are infrequently transferred due to contractual or other
legal restrictions. The amendment is not expected to have a material impact on the Companys
results of operations, cash flows or financial position.
The Company will adopt the following new accounting standards as of January 1, 2010, the first
day of its 2010 fiscal year:
Accounting
for Transfers of Financial Assets an amendment of ASC topic
860, Transfers and Servicing: In June 2009, the FASB issued an amendment to ASC topic 860, Transfers and Servicing, to
improve the information that is reported in financial statements about the transfer of
financial assets and the effects of transfers of financial assets on financial position,
financial performance and cash flows and a transferors continuing involvement, if any, with
transferred financial assets. In addition, the amendment eliminates the concept of qualifying
special purpose entities and limits the circumstances in which a financial asset or a portion
of a financial asset should be derecognized in the financial statements being presented when
the transferor has not transferred the entire original financial asset to an entity that is
not consolidated with the transferor and/or when the
transferor has continuing involvement with the transferred financial asset.
Upon the adoption of this amendment in the first quarter of 2010 the accounts receivable
that the Company had previously treated as sold and removed from the balance sheet will
be included in accounts receivable, net and the amounts outstanding under the
Companys Accounts Receivable Securitization Program will be accounted for as a
secured borrowing and reflected as short-term debt on our balance sheet (which as of
September 27, 2009 is $39.7 million for both).
8
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Amendment
to ASC topic 810, Consolidation: In June 2009, the FASB issued an amendment to ASC topic 810,
Consolidation, that requires an enterprise to perform an analysis to determine whether the
enterprises variable interest or interests give it a controlling financial interest in a
variable interest entity (which would result in the enterprise being deemed the primary
beneficiary of that entity and, therefore, obligated to consolidate the variable interest
entity in its financial statements); to require ongoing reassessments of whether an
enterprise is the primary beneficiary of a variable interest entity; to revise guidance for
determining whether an entity is a variable interest entity; and to require enhanced
disclosures that will provide more transparent information about an enterprises involvement
with a variable interest entity. The Company is currently evaluating the provisions of the
amendment to determine the impact on the Companys results of operations, cash flows and financial position.
Note 3 Integration
Integration of Arrow
In connection with the acquisition of Arrow International, Inc. (Arrow) in October 2007, the
Company formulated a plan related to the integration of Arrow and the Companys Medical businesses.
The integration plan focuses on the closure of Arrow corporate functions and the consolidation of
manufacturing, sales, marketing, and distribution functions in North America, Europe and Asia. The
Company finalized its estimate of the costs to implement the plan in the fourth quarter of 2008.
The Company has accrued estimates for certain costs, related primarily to personnel reductions and
facility closures and the termination of certain distribution agreements at the date of
acquisition.
The following table provides information relating to changes in the accrued liability
associated with the Arrow integration plan during the nine months ended September 27, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Adjustments to |
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
|
2008 |
|
|
Reserve |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in millions) |
|
Termination benefits |
|
$ |
4.3 |
|
|
$ |
(0.3 |
) |
|
$ |
(0.1 |
) |
|
$ |
|
|
|
$ |
3.9 |
|
Facility closure costs |
|
|
0.8 |
|
|
|
|
|
|
|
(0.2 |
) |
|
|
|
|
|
|
0.6 |
|
Contract termination costs |
|
|
4.8 |
|
|
|
0.1 |
|
|
|
(1.9 |
) |
|
|
(0.3 |
) |
|
|
2.7 |
|
Other integration costs |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10.6 |
|
|
$ |
(0.2 |
) |
|
$ |
(2.2 |
) |
|
$ |
(0.3 |
) |
|
$ |
7.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
termination benefits are expected to be paid in 2010. The facility
closure costs consist of payments for leased facilities that will
extend to 2013. Approximately $2.1 million of the
contract termination costs will be paid in the next six months to terminate a European distributor
agreement.
In conjunction with the plan for the integration of Arrow and the Companys Medical
businesses, the Company has taken actions that affect employees and facilities of Teleflex. This
aspect of the integration plan is explained in Note 4, Restructuring. Costs that affect employees
and facilities of Teleflex are charged to earnings and included in restructuring and other
impairment charges within the condensed consolidated statement of operations for the periods in
which the costs are incurred.
9
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 4 Restructuring and other impairment charges
The amounts included in restructuring and other impairment charges in the condensed
consolidated statement of income for the three and nine month periods ended September 27, 2009 and
September 28, 2008 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
2008 Commercial Segment Restructuring Program |
|
$ |
185 |
|
|
$ |
|
|
|
$ |
2,240 |
|
|
$ |
|
|
2007 Arrow Integration Program |
|
|
1,284 |
|
|
|
432 |
|
|
|
5,384 |
|
|
|
11,212 |
|
2006 Restructuring Program |
|
|
|
|
|
|
38 |
|
|
|
|
|
|
|
705 |
|
Impairment charges intangibles and fixed assets |
|
|
3,314 |
|
|
|
|
|
|
|
5,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other impairment charges |
|
$ |
4,783 |
|
|
$ |
470 |
|
|
$ |
13,412 |
|
|
$ |
11,917 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 Commercial Segment Restructuring Program
In December 2008, the Company began certain restructuring initiatives with respect to the
Companys Commercial Segment. These initiatives involve the consolidation of operations and a
related reduction in workforce at certain of the Companys facilities in North America and Europe.
The Company determined to undertake these initiatives as a means to improve operating performance
and to better leverage its existing resources in light of expected continued weakness in the marine
and industrial markets.
The charges associated with the 2008 Commercial Segment restructuring program that are
included in restructuring and other impairment charges in the condensed consolidated statements of
income during the three and nine month periods ended September 27, 2009 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Commercial |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, 2009 |
|
|
September 27, 2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
100 |
|
|
$ |
2,027 |
|
Facility closure costs |
|
|
85 |
|
|
|
213 |
|
|
|
|
|
|
|
|
|
|
$ |
185 |
|
|
$ |
2,240 |
|
|
|
|
|
|
|
|
The following table provides information relating to changes in the accrued liability
associated with the 2008 Commercial Segment restructuring program during the nine months ended
September 27, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Subsequent |
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
|
2008 |
|
|
Accruals |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
449 |
|
|
$ |
2,027 |
|
|
$ |
(2,430 |
) |
|
$ |
7 |
|
|
$ |
53 |
|
Facility closure costs |
|
|
|
|
|
|
213 |
|
|
|
(213 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
449 |
|
|
$ |
2,240 |
|
|
$ |
(2,643 |
) |
|
$ |
7 |
|
|
$ |
53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 27, 2009, the Company has substantially
completed the 2008 Commercial Segment restructuring program.
Termination benefits are comprised of severance-related payments for all employees terminated
in connection with the 2008 Commercial Segment restructuring program. Facility closure costs relate
primarily to costs to prepare a facility for closure.
10
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2007 Arrow Integration Program
The charges associated with the 2007 Arrow integration program that were included in
restructuring and other impairment charges for the three and nine month periods ended September 27,
2009 and September 28, 2008, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
679 |
|
|
$ |
44 |
|
|
$ |
3,243 |
|
|
$ |
9,882 |
|
Facility closure costs |
|
|
193 |
|
|
|
|
|
|
|
409 |
|
|
|
|
|
Contract termination costs |
|
|
157 |
|
|
|
63 |
|
|
|
1,048 |
|
|
|
869 |
|
Other restructuring costs |
|
|
255 |
|
|
|
325 |
|
|
|
684 |
|
|
|
461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,284 |
|
|
$ |
432 |
|
|
$ |
5,384 |
|
|
$ |
11,212 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table provides information relating to changes in the accrued liability
associated with the 2007 Arrow integration program during the nine
months ended September 27, 2009. Subsequent accruals represent the recognition of non-accruable restructuring expenses in the period in which the
expense has been incurred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Subsequent |
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
|
2008 |
|
|
Accruals |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
7,815 |
|
|
$ |
3,243 |
|
|
$ |
(7,793 |
) |
|
$ |
(149 |
) |
|
$ |
3,116 |
|
Facility closure costs |
|
|
601 |
|
|
|
409 |
|
|
|
(383 |
) |
|
|
9 |
|
|
|
636 |
|
Contract termination costs |
|
|
|
|
|
|
1,048 |
|
|
|
(688 |
) |
|
|
25 |
|
|
|
385 |
|
Other restructuring costs |
|
|
159 |
|
|
|
684 |
|
|
|
(821 |
) |
|
|
2 |
|
|
|
24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8,575 |
|
|
$ |
5,384 |
|
|
$ |
(9,685 |
) |
|
$ |
(113 |
) |
|
$ |
4,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination benefits are comprised of severance-related payments for all employees terminated
in connection with the 2007 Arrow integration program. Facility closure costs relate primarily to
costs to prepare a facility for closure. Contract termination costs relate primarily to the
termination of leases in conjunction with the consolidation of facilities.
As of September 27, 2009, the Company expects to incur the following restructuring expenses
associated with the 2007 Arrow integration program in its Medical Segment through December 2010:
|
|
|
|
|
|
|
(Dollars in millions) |
|
Termination benefits |
|
$ |
1.5 2.5 |
|
Facility closure costs |
|
|
0.2 0.4 |
|
Contract termination costs |
|
|
0.5 0.8 |
|
Other restructuring costs |
|
|
0.7 1.0 |
|
|
|
|
|
|
|
$ |
2.9 4.7 |
|
|
|
|
|
During
the third quarter of 2009 the Company revised the 2007 Arrow
integration program
resulting in a $2 million reduction in termination benefits due to a decision to retain certain
functions in Europe and a $5 million reduction in contract termination costs due to a decision to
maintain certain distributor relationships in Asia.
2006 Restructuring Program
In June 2006, the Company began certain restructuring initiatives that affected all three
of the Companys reporting segments. These initiatives involved the consolidation of operations and
a related reduction in workforce at several of the Companys facilities in Europe and North
America. The Company determined to undertake these initiatives as a means to improving operating
performance and to better leverage the Companys existing resources.
11
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the three and nine month periods ended September 28, 2008, the charges associated with the
2006 restructuring program that are included in restructuring and other impairment charges were as
follows:
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 28, |
|
|
September 28, |
|
|
|
2008 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
|
|
|
$ |
589 |
|
Contract termination costs |
|
|
38 |
|
|
|
116 |
|
|
|
|
|
|
|
|
|
|
$ |
38 |
|
|
$ |
705 |
|
|
|
|
|
|
|
|
Termination benefits were comprised of severance-related payments for all employees terminated
in connection with the 2006 restructuring program. Contract termination costs related primarily to
the termination of leases in conjunction with the consolidation of facilities. The 2006
Restructuring Program ceased December 31, 2008, no costs were incurred under this program in 2009.
The accrued liability at September 27, 2009 and December 31, 2008 was nominal.
Impairment Charges
During the second quarter of 2009, the Company recorded $2.3 million in impairment charges
with respect to an intangible asset in the Commercial Segment.
In 2004, the Company contributed property and other assets that had
been part of one of its former manufacturing sites to a real estate venture in California.
During the third quarter of 2009, based on continued deterioration in the California real estate market, the
Company concluded that its investment was not recoverable and recorded $3.3 million in impairment
charges to fully write-off its investment in this venture.
See Note 5 Impairment of Goodwill
and Intangible Assets for a discussion of the charge.
Note 5 Impairment of Goodwill and Intangible Assets
The Company performed an interim review of goodwill and intangible assets in the Marine and
Cargo Container reporting units during the second quarter of 2009 and determined that $6.7 million
of goodwill in the Cargo Container operations and $2.3 million of indefinite lived tradenames in
the Marine operations were impaired. The Company performed this interim review as a result of the
difficult market conditions in which these reporting units are currently operating and the
significant deterioration in the operating performance of these reporting units which accelerated
in the second quarter of 2009.
In performing the goodwill impairment test, the Company estimated the fair values of these two
reporting units by a combination of (i) estimation of the discounted cash flows of each of the
reporting units based on projected earnings in the future (the income approach) and (ii) analysis
of sales of similar assets in actual transactions (the market approach). Using this methodology,
the Company determined that the entire $6.7 million of goodwill in the Cargo Container reporting
unit was impaired, but that goodwill in the Marine reporting unit was not impaired. In performing
the impairment test for the indefinite lived intangibles, the Company estimated the direct cash
flows associated with the applicable intangible assets using a relief from royalty methodology
associated with revenues projected to be generated from these intangibles. Under this methodology,
the owner of an intangible asset must determine the arms length royalty that likely would have been
charged if the owner had to license that asset from a third party. This analysis indicated that
certain tradenames in the Marine reporting unit were impaired by $2.3 million.
Note 6 Inventories
Inventories consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Raw
materials |
|
$ |
164,977 |
|
|
$ |
185,270 |
|
Work-in-process |
|
|
61,284 |
|
|
|
55,618 |
|
Finished goods |
|
|
205,389 |
|
|
|
221,281 |
|
|
|
|
|
|
|
|
|
|
|
431,650 |
|
|
|
462,169 |
|
Less: Inventory
reserve |
|
|
(36,416 |
) |
|
|
(37,516 |
) |
|
|
|
|
|
|
|
Inventories |
|
$ |
395,234 |
|
|
$ |
424,653 |
|
|
|
|
|
|
|
|
12
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note
7 Goodwill and other intangible assets
Changes in the carrying amount of goodwill, by operating segment, for the nine months ended
September 27, 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
|
Aerospace |
|
|
Commercial |
|
|
Total |
|
|
|
(Dollars in thousands) |
|
Goodwill at December 31,
2008 |
|
$ |
1,426,031 |
|
|
$ |
6,996 |
|
|
$ |
41,096 |
|
|
$ |
1,474,123 |
|
Acquisitions |
|
|
214 |
|
|
|
|
|
|
|
|
|
|
|
214 |
|
Adjustment to acquisition
balance sheet |
|
|
(525 |
) |
|
|
|
|
|
|
|
|
|
|
(525 |
) |
Dispositions |
|
|
|
|
|
|
(268 |
) |
|
|
(27,181 |
) |
|
|
(27,449 |
) |
Impairment |
|
|
|
|
|
|
(6,728 |
) |
|
|
|
|
|
|
(6,728 |
) |
Translation
adjustment |
|
|
26,022 |
|
|
|
|
|
|
|
1,172 |
|
|
|
27,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill at September 27,
2009 |
|
$ |
1,451,742 |
|
|
$ |
|
|
|
$ |
15,087 |
|
|
$ |
1,466,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The $6.7 million impairment charge recognized during the second quarter represents the
impairment of goodwill for the Cargo Container reporting unit in the Aerospace Segment. See Note 5
for further discussion on the goodwill impairment charge.
The dispositions relate to the sale of the ATI (Aerospace) and Power Systems
(Commercial) businesses in the first and third quarters of 2009, respectively.
Intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
|
September 27, |
|
|
December 31, |
|
|
September 27, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Customer
lists |
|
$ |
560,643 |
|
|
$ |
553,786 |
|
|
$ |
67,896 |
|
|
$ |
48,311 |
|
Intellectual
property |
|
|
208,543 |
|
|
|
221,549 |
|
|
|
55,233 |
|
|
|
53,437 |
|
Distribution
rights |
|
|
22,890 |
|
|
|
26,833 |
|
|
|
16,414 |
|
|
|
16,422 |
|
Trade
names |
|
|
337,536 |
|
|
|
333,495 |
|
|
|
3,579 |
|
|
|
875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,129,612 |
|
|
$ |
1,135,663 |
|
|
$ |
143,122 |
|
|
$ |
119,045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense related to intangible assets was approximately $11.1 million and $11.2
million for the three months ended and $32.9 million and $34.3 million for the nine months ended
September 27, 2009 and September 28, 2008, respectively. Estimated annual amortization expense for
each of the five succeeding years is as follows (dollars in thousands):
|
|
|
|
|
2009 |
|
$ |
44,300 |
|
2010 |
|
|
44,500 |
|
2011 |
|
|
44,300 |
|
2012 |
|
|
43,400 |
|
2013 |
|
|
42,100 |
|
Note 8 Financial instruments
The Company uses derivative instruments for risk management purposes. Forward rate contracts
are used to manage foreign currency transaction exposure and interest rate swaps are used to reduce
exposure to interest rate changes. In accordance with ASC topic 815, Derivatives and Hedging,
these derivative instruments are designated as cash flow hedges and are recorded on the balance
sheet at fair market value. The effective portion of the gains or losses on derivatives are
reported as a component of other comprehensive income and reclassified into earnings in the same
period or periods during which the hedged transaction affects earnings. Gains and losses on the
derivative representing either hedge ineffectiveness or hedge components excluded from the
assessment of effectiveness are recognized in current earnings. See Note 9, Fair Value Measurement for
additional information.
13
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The location and fair values of derivative instruments designated as hedging instruments under
ASC topic 815, Derivatives and Hedging in the condensed consolidated balance sheet are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Values of Derivative Instruments |
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
As of September 27, 2009 |
|
|
|
(Dollars in thousands) |
|
|
|
|
|
|
|
Fair |
|
|
|
|
|
|
Fair |
|
|
|
Balance Sheet Location |
|
Value |
|
|
Balance Sheet Location |
|
Value |
|
Interest rate contracts |
|
|
|
|
$ |
|
|
|
Derivative liabilities current |
|
$ |
16,842 |
|
Interest rate contracts |
|
|
|
|
|
|
|
|
Other liabilities noncurrent |
|
|
14,490 |
|
Foreign exchange contracts |
|
Other assets current |
|
|
1,234 |
|
|
Derivative liabilities current |
|
|
1,398 |
|
Foreign exchange contracts |
|
|
|
|
|
|
|
|
Other liabilities noncurrent |
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives |
|
|
|
|
|
$ |
1,234 |
|
|
|
|
|
|
$ |
32,836 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The location and amount of the gains and losses for derivatives in cash flow hedging
relationships as defined under ASC topic 815, Derivatives and Hedging, that were reported in
other comprehensive income (OCI), accumulated other comprehensive income (AOCI) and the
condensed consolidated statement of income for the three and nine months periods ended September
27, 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 27, 2009 |
|
|
|
Effective Portion |
|
|
|
Gain/(Loss) |
|
|
|
|
|
|
Recognized |
|
|
|
|
|
|
in OCI |
|
|
(Gain)/Loss Reclassified from AOCI into Income |
|
|
|
After Tax |
|
|
|
|
|
|
Pre-Tax |
|
|
|
Amount |
|
|
Location |
|
Amount |
|
|
|
(Dollars in thousands) |
|
Interest rate contracts |
|
$ |
(334 |
) |
|
Interest expense |
|
$ |
5,164 |
|
Foreign exchange contracts |
|
|
405 |
|
|
Net revenues |
|
|
(548 |
) |
Foreign exchange contracts |
|
|
|
|
|
Materials, labor and other product costs |
|
|
694 |
|
Foreign exchange contracts |
|
|
|
|
|
Selling, engineering, and administrative expenses |
|
|
(287 |
) |
Foreign exchange contracts |
|
|
|
|
|
Income from discontinued operations |
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
71 |
|
|
|
|
|
|
$ |
5,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 27, 2009 |
|
|
|
Effective Portion |
|
|
|
Gain |
|
|
|
|
|
|
Recognized |
|
|
|
|
|
|
in OCI |
|
|
(Gain)/Loss Reclassified from AOCI into Income |
|
|
|
After Tax |
|
|
|
|
|
|
Pre-Tax |
|
|
|
Amount |
|
|
Location |
|
Amount |
|
|
|
(Dollars in thousands) |
|
Interest rate contracts |
|
$ |
8,928 |
|
|
Interest expense |
|
$ |
14,275 |
|
Foreign exchange contracts |
|
|
4,930 |
|
|
Net revenues |
|
|
225 |
|
Foreign exchange contracts |
|
|
|
|
|
Materials, labor and other product costs |
|
|
2,816 |
|
Foreign exchange contracts |
|
|
|
|
|
Selling, engineering, and administrative expenses |
|
|
(287 |
) |
Foreign exchange contracts |
|
|
|
|
|
Income from discontinued operations |
|
|
235 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
13,858 |
|
|
|
|
|
|
$ |
17,264 |
|
|
|
|
|
|
|
|
|
|
|
|
For the three months and nine months ended September 27, 2009, there was no
ineffectiveness related to the Companys derivatives.
14
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 9 Fair value measurement
The Company endeavors to utilize the best available information in measuring fair value in
accordance with the valuation hierarchy described below. The Company has determined the fair value
of its financial assets based on Level 1 and Level 2 inputs and the fair value of its financial
liabilities based on Level 2 inputs in accordance with the valuation hierarchy.
Valuation Hierarchy
The Derivatives and Hedging Standard establishes a valuation hierarchy of the inputs used
to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:
Level 1 inputs quoted prices (unadjusted) in active markets for identical assets or
liabilities that the Company has ability to access at the measurement date.
Level 2 inputs inputs other than quoted prices included within Level 1 that are observable
for the asset or liability, either directly or indirectly. If the asset or liability has a
specified (contractual) term, a Level 2 input must be observable for substantially the full term of
the asset or liability. Level 2 inputs include:
1. Quoted prices for similar assets or liabilities in active markets.
2. Quoted prices for identical or similar assets or liabilities in markets that are not
active.
3. Inputs other than quoted prices that are observable for the asset or liability.
4. Inputs that are derived principally from or corroborated by observable market data by
correlation or other means.
Level 3 inputs unobservable inputs for the asset or liability. Unobservable inputs may
be used to measure fair value only when observable inputs are not available. Unobservable inputs
reflect the Companys assumptions about the assumptions market participants would use in pricing
the asset or liability in achieving the fair value measurement objective of an exit price
perspective.
A financial asset or liabilitys classification within the hierarchy is determined based
on the lowest level input that is significant to the fair value measurement.
The following tables provide the financial assets and liabilities carried at fair value
measured on a recurring basis as of September 27, 2009 and September 28, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total carrying |
|
|
|
|
|
|
|
|
|
|
|
|
value at |
|
|
Quoted prices in |
|
|
Significant other |
|
|
Significant |
|
|
|
September 27, |
|
|
active markets |
|
|
observable inputs |
|
|
unobservable |
|
|
|
2009 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
inputs (Level 3) |
|
|
|
(Dollars in thousands) |
|
Deferred compensation assets |
|
$ |
3,000 |
|
|
$ |
3,000 |
|
|
$ |
|
|
|
$ |
|
|
Derivative assets |
|
$ |
1,234 |
|
|
$ |
|
|
|
$ |
1,234 |
|
|
$ |
|
|
Derivative liabilities |
|
$ |
32,836 |
|
|
$ |
|
|
|
$ |
32,836 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total carrying |
|
|
|
|
|
|
|
|
|
|
|
|
value at |
|
|
Quoted prices in |
|
|
Significant other |
|
|
Significant |
|
|
|
September 28, |
|
|
active markets |
|
|
observable inputs |
|
|
unobservable |
|
|
|
2008 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
inputs (Level 3) |
|
|
|
(Dollars in thousands) |
|
Deferred compensation assets |
|
$ |
3,272 |
|
|
$ |
3,272 |
|
|
$ |
|
|
|
$ |
|
|
Derivative assets |
|
$ |
578 |
|
|
$ |
|
|
|
$ |
578 |
|
|
$ |
|
|
Derivative liabilities |
|
$ |
17,873 |
|
|
$ |
|
|
|
$ |
17,873 |
|
|
$ |
|
|
The carrying amount reported in the condensed consolidated balance sheet as of September 27,
2009 for long-term debt is $1,249.8 million. Using a discounted cash flow technique that
incorporates a market interest yield curve with adjustments for duration, optionality, and risk
profile, the Company has determined the fair value of its debt to be $1,165.4 million at September
27, 2009. The Companys implied credit rating is a factor in determining the market interest yield
curve.
15
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Valuation Techniques
The Companys financial assets valued based upon Level 1 inputs are comprised of
investments in marketable securities held in a rabbi trust, which may be used to fund benefits
under certain deferred compensation plans. Under these deferred compensation plans, participants
designate investment options to serve as the basis for measurement of the notional value of their
accounts. The investment assets of the rabbi trust are valued using quoted market prices multiplied
by the number of shares held in the trust.
The Companys financial assets valued based upon Level 2 inputs are comprised of foreign
currency forward contracts. The Companys financial liabilities valued based upon Level 2 inputs
are comprised of an interest rate swap contract and foreign currency forward contracts. The Company
takes into account the counterparties or its own creditworthiness in measuring fair value. The fair value of the interest rate swap contract is
developed from market-based inputs under the income approach using cash flows discounted at
relevant market interest rates which is then adjusted for the Companys creditworthiness using a
credit default swap rate. The fair value of the foreign currency forward exchange contracts
represents the amount required to enter into offsetting contracts with similar remaining maturities
based on quoted market prices. See Note 8, Financial
Instruments for additional information.
Note
10 Changes in shareholders equity
Set forth below is a reconciliation of the Companys issued common shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Shares in thousands) |
|
Common shares,
beginning of
period |
|
|
42,005 |
|
|
|
41,932 |
|
|
|
41,995 |
|
|
|
41,794 |
|
Shares issued under
compensation
plans |
|
|
10 |
|
|
|
52 |
|
|
|
20 |
|
|
|
190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, end
of
period |
|
|
42,015 |
|
|
|
41,984 |
|
|
|
42,015 |
|
|
|
41,984 |
|
Less: Treasury
shares, end of
period |
|
|
2,288 |
|
|
|
2,320 |
|
|
|
2,288 |
|
|
|
2,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding shares,
end of
period |
|
|
39,727 |
|
|
|
39,664 |
|
|
|
39,727 |
|
|
|
39,664 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On June 14, 2007, the Companys Board of Directors authorized the repurchase of up to $300
million of outstanding Company common stock. Repurchases of Company stock under the Board
authorization may be made from time to time in the open market and may include privately-negotiated
transactions as market conditions warrant and subject to regulatory considerations. The stock
repurchase program has no expiration date and the Companys ability to execute on the program will
depend on, among other factors, cash requirements for acquisitions, cash generation from
operations, debt repayment obligations, market conditions and regulatory requirements. In
addition, the Companys senior loan agreements limit the aggregate amount of share repurchases and
other restricted payments the Company may make to $75 million per year in the event the Companys
consolidated leverage ratio (generally consolidated total indebtedness to consolidated EBITDA,
as such terms are defined in the senior loan agreements) exceeds 3.5 to 1. Accordingly, these
provisions may limit the Companys ability to repurchase shares under this Board authorization.
Through September 27, 2009, no shares have been purchased under this Board authorization.
Basic earnings per share is computed by dividing net income by the weighted average number of
common shares outstanding during the period. Diluted earnings per share is computed in the same
manner except that the weighted average number of shares is increased for dilutive securities. The
difference between basic and diluted weighted average common shares results from the assumption
that dilutive share-based payment awards were exercised or vested at the beginning of the period. A
reconciliation of basic to diluted weighted average shares outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Shares in thousands) |
|
Basic |
|
|
39,724 |
|
|
|
39,645 |
|
|
|
39,711 |
|
|
|
39,553 |
|
Dilutive shares assumed issued |
|
|
208 |
|
|
|
325 |
|
|
|
199 |
|
|
|
284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
39,932 |
|
|
|
39,970 |
|
|
|
39,910 |
|
|
|
39,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Weighted average stock options that were anti-dilutive and therefore not included in the
calculation of earnings per share were approximately 1,923 thousand and 1,807 thousand for the
three and nine month periods ended September 27, 2009 and approximately 666 thousand and 908
thousand for the three and nine month periods ended September 28, 2008, respectively.
Note 11 Stock compensation plans
The Company has two stock-based compensation plans under which equity-based awards may be
made. The Companys 2000 Stock Compensation Plan (the 2000 plan) provides for the granting of
incentive and non-qualified stock options and restricted stock awards to directors, officers and
key employees. Under the 2000 plan, the Company is authorized to issue up to 4 million shares of
common stock, but no more than 800,000 of those shares may be issued as restricted stock. Options
granted under the 2000 plan have an exercise price equal to the average of the high and low sales
prices of the Companys common stock on the date of the grant, rounded to the nearest $0.25.
Generally, options granted under the 2000 plan are exercisable three to five years after the date
of the grant and expire no more than ten years after the grant date. Restricted stock awards
generally vest in one to three years. During the first nine months of 2009, the Company granted
non-qualified options to purchase 5,000 shares of common stock and granted restricted stock awards
representing 170,159 shares of common stock under the 2000 plan.
The Companys 2008 Stock Incentive Plan (the 2008 plan) provides for the granting of various
types of equity-based awards to directors, officers and key employees. These awards include
incentive and non-qualified stock options, stock appreciation rights, stock awards and other
stock-based awards. Under the 2008 plan, the Company is authorized to issue up to 2.5 million
shares of common stock, but grants of awards other than stock options and stock appreciation rights
may not exceed 875,000 shares. Options granted under the 2008 plan have an exercise price equal to
the closing price of the Companys common stock on the date of grant. Generally, options granted
under the 2008 plan are exercisable three years after the date of the grant and expire no more than
ten years after the grant date. During the first nine months of 2009, the Company granted incentive
and non-qualified options to purchase 452,644 shares of common stock under the 2008 plan.
Note 12 Income taxes
The
effective income tax rate for the three months ended September 27, 2009 was 28.2% compared
to 31.6% for the corresponding prior year period. The effective income tax rate for the nine months
ended September 27, 2009 was 23.6% compared to 33.6% for the corresponding prior year period. The
principal factors affecting the comparability of the effective income tax rate for the three month
period are the beneficial net impact of discrete tax charges in the third quarter of 2009,
including a net reduction in income tax reserves related to the expiration of statutes of
limitation for various uncertain tax positions, the settlement of tax audits, and adjustments to
previously filed tax returns, partially offset by the impact of 2009 foreign income inclusions that
will be immediately taxed in the U.S. The principal factors affecting the comparability of the
effective income tax rate for the nine month period are the beneficial net impact of discrete tax
charges in 2009, including a net reduction in income tax reserves related to the expiration of
statutes of limitation for various uncertain tax positions, the settlement of tax audits, and
adjustments to previously filed tax returns, partially offset by the impact of 2009 foreign income
inclusions that will be immediately taxed in the U.S. and the impairment loss of $6.7 million on
non-deductible goodwill for which there is no income tax benefit.
Note 13 Pension and other postretirement benefits
The Company has a number of defined benefit pension and postretirement plans covering eligible
U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits
under these plans are based primarily on years of service and employees pay near retirement. The
Companys funding policy for U.S. plans is to contribute annually, at a minimum, amounts required
by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided
for by depositing funds with trustees or by book reserves.
In 2009, the Company offered certain qualifying individuals an early retirement program. Based
on the individuals that accepted the offer the Company recognized special termination benefits of
$402 thousand in pension expense and $395 thousand in postretirement expense in the second quarter
of 2009.
In 2008, the Company took the following actions with respect to its pension benefits:
Effective August 31, 2008, the Arrow Salaried plan, the Arrow Hourly plan and the
Berks plan were merged into the Teleflex Retirement Income Plan (TRIP).
On October 31, 2008, the TRIP was amended to cease future benefit accruals for all
employees, other than those subject to a collective bargaining agreement, as of December 31,
2008.
On December 15, 2008, the Company amended its Supplemental Executive Retirement
Plans (SERP) for all executives to cease future benefit accruals as of December 31, 2008. In
addition, the Company approved a plan to replace the non-qualified defined benefits provided
under the SERP with a non-qualified defined contribution arrangement under the Companys
Deferred Compensation Plan, effective January 1, 2009.
17
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In addition, on October 31, 2008, the Companys postretirement benefit plans were amended to
eliminate future benefits for employees, other than those subject to a collective bargaining
agreement, who had not attained age 50 and whose age plus service was less than 65.
The Company and certain of its subsidiaries provide medical, dental and life insurance
benefits to pensioners and survivors. The associated plans are unfunded and approved claims are
paid from Company funds.
Net benefit cost of pension and postretirement benefit plans consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension |
|
|
Other Benefits |
|
|
Pension |
|
|
Other Benefits |
|
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Service cost |
|
$ |
619 |
|
|
$ |
941 |
|
|
$ |
87 |
|
|
$ |
486 |
|
|
$ |
2,036 |
|
|
$ |
3,597 |
|
|
$ |
654 |
|
|
$ |
980 |
|
Interest cost |
|
|
4,861 |
|
|
|
4,599 |
|
|
|
718 |
|
|
|
1,170 |
|
|
|
13,890 |
|
|
|
13,910 |
|
|
|
2,518 |
|
|
|
2,665 |
|
Expected return on
plan assets |
|
|
(3,796 |
) |
|
|
(5,804 |
) |
|
|
|
|
|
|
|
|
|
|
(11,173 |
) |
|
|
(17,446 |
) |
|
|
|
|
|
|
|
|
Net amortization and
deferral |
|
|
983 |
|
|
|
446 |
|
|
|
141 |
|
|
|
266 |
|
|
|
3,461 |
|
|
|
1,388 |
|
|
|
582 |
|
|
|
797 |
|
Special
termination costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
402 |
|
|
|
|
|
|
|
395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net benefit cost |
|
$ |
2,667 |
|
|
$ |
182 |
|
|
$ |
946 |
|
|
$ |
1,922 |
|
|
$ |
8,616 |
|
|
$ |
1,449 |
|
|
$ |
4,149 |
|
|
$ |
4,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 14 Commitments and contingent liabilities
Product warranty liability: The Company warrants to the original purchaser of certain of
its products that it will, at its option, repair or replace, without charge, such products if they
fail due to a manufacturing defect. Warranty periods vary by product. The Company has recourse
provisions for certain products that would enable recovery from third parties for amounts paid
under the warranty. The Company accrues for product warranties when, based on available
information, it is probable that customers will make claims under warranties relating to products
that have been sold, and a reasonable estimate of the costs (based on historical claims experience
relative to sales) can be made. Set forth below is a reconciliation of the Companys estimated
product warranty liability for the nine months ended September 27, 2009 (dollars in thousands):
|
|
|
|
|
Balance December 31, 2008 |
|
$ |
17,106 |
|
Accruals for warranties issued in
2009 |
|
|
5,697 |
|
Settlements (cash and in
kind) |
|
|
(5,948 |
) |
Accruals related to pre-existing
warranties |
|
|
791 |
|
Dispositions |
|
|
(8,596 |
) |
Effect of
translation |
|
|
999 |
|
|
|
|
|
Balance September 27, 2009
|
|
$ |
10,049 |
|
|
|
|
|
The dispositions relate to the sale of the Power Systems (Commercial Segment) business in the third quarter of 2009.
Operating leases: The Company uses various leased facilities and equipment in its
operations. The terms for these leased assets vary depending on the lease agreement. In connection
with these operating leases, the Company had residual value guarantees in the amount of
approximately $1.9 million at September 27, 2009. The Companys future payments under the operating
leases cannot exceed the minimum rent obligation plus the residual value guarantee amount. The
residual value guarantee amounts are based upon the unamortized lease values of the assets under
lease, and are payable by the Company if the Company declines to renew the leases or to exercise
its purchase option with respect to the leased assets. At September 27, 2009, the Company had no
liabilities recorded for these obligations. Any residual value guarantee amounts paid to the lessor
may be recovered by the Company from the sale of the assets to a third party.
18
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Accounts receivable securitization program: The Company uses an accounts receivable
securitization program to gain access to credit markets with favorable interest rates and reduce
financing costs. As currently structured, accounts receivable of certain domestic subsidiaries are
sold on a non-recourse basis to a special purpose entity (SPE), which is a bankruptcy-remote consolidated subsidiary of
Teleflex. This SPE then sells undivided interests in those receivables to an asset backed
commercial paper conduit. The conduit issues notes secured by those interests and other assets to
third party investors.
To the extent that cash consideration is received for the sale of undivided interests in the
receivables by the SPE to the conduit, it is accounted for as a sale in accordance with ASC topic
860, Transfers and Servicing, as the Company has relinquished control of the receivables.
Accordingly, undivided interests in accounts receivable sold to the commercial paper conduit under
these transactions are excluded from accounts receivable, net in the accompanying condensed
consolidated balance sheets. The interests for which cash consideration is not received from the
conduit are retained by the SPE and remain in accounts receivable, net in the accompanying condensed
consolidated balance sheets.
The interests in receivables sold and the interest in receivables retained by the SPE are
carried at face value, which is due to the short-term nature of our accounts receivable. The SPE
has received cash consideration of $39.7 million and $39.7 million for the interests in the
accounts receivable it has sold to the commercial paper conduit at September 27, 2009 and December
31, 2008, respectively. No gain or loss is recorded upon sale as fee charges from the commercial
paper conduit are based upon a floating yield rate and the period the undivided interests remain
outstanding. Fee charges from the commercial paper conduit are accrued at the end of each month. If
the Company defaults under the accounts receivable securitization program, the commercial paper
conduit is entitled to receive collections on receivables owned by the SPE in satisfaction of the
amount of cash consideration paid to the SPE by the commercial paper conduit. The assets of the SPE
are not available to satisfy the obligations of Teleflex or any of its other subsidiaries.
Information regarding the outstanding balances related to the SPEs interests in accounts
receivables sold or retained as of September 27, 2009 is as follows:
|
|
|
|
|
|
|
(Dollars in millions) |
|
Interests in receivables sold outstanding (1) |
|
$ |
39.7 |
|
Interests in receivables retained, net of allowance for doubtful accounts |
|
$ |
79.3 |
|
|
|
|
(1) |
|
Deducted from accounts receivable, net in the condensed consolidated balance sheets. |
The delinquency ratio for the qualifying receivables represented 4.5% of the total qualifying
receivables as of September 27, 2009.
The following table summarizes the activity related to our interests in accounts receivable
sold for the three and nine month periods ended September 27, 2009:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, 2009 |
|
|
September 27, 2009 |
|
|
|
(Dollars in millions) |
|
Proceeds from the sale of interest in accounts receivable |
|
$ |
|
|
|
$ |
35.0 |
|
Fees and charges (1) |
|
$ |
0.3 |
|
|
$ |
0.9 |
|
|
|
|
(1) |
|
Recorded in interest expense in the condensed consolidated statement of
operations. |
Other fee charges related to the sale of receivables to the commercial paper conduit for the
three and nine month periods ended September 27, 2009 were not material.
The Company continues to service the receivables after they are sold to the conduit pursuant
to servicing agreements with the SPE. No servicing asset is recorded at the time of sale because
the Company does not receive any servicing fees from third parties or other income related to the
servicing of the receivables. The Company does not record any servicing liability at the time of
the sale as the receivables collection period is relatively short and the costs of servicing the
receivables sold over the servicing period are insignificant. Servicing costs are recognized as
incurred over the servicing period.
In the first quarter of 2010, the Company will adopt an amendment to ASC topic
860, Transfers and Servicing that affects the accounting for transfers of financial assets.
The accounts receivable that the Company had previously treated as sold and removed
from the balance sheet will be included in accounts receivable, net and the amounts
outstanding under the Companys accounts receivable
securitization program will be
accounted for as a secured borrowing and reflected as short-term debt on our balance
sheet (which as of September 27, 2009 is $39.7 million for both).
19
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Environmental: The Company is subject to contingencies as a result of environmental laws
and regulations that in the future may require the Company to take further action to correct the
effects on the environment of prior disposal practices or releases of chemical or petroleum
substances by the Company or other parties. Much of this liability results from the U.S.
Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), often referred to
as Superfund, the U.S. Resource Conservation and Recovery Act (RCRA) and similar state laws.
These laws require the Company to undertake certain investigative and remedial activities at sites
where the Company conducts or once conducted operations or at sites where Company-generated waste
was disposed.
Remediation activities vary substantially in duration and cost from site to site. These
activities, and their associated costs, depend on the mix of unique site characteristics, evolving
remediation technologies, diverse regulatory agencies and enforcement policies, as well as the
presence or absence of other potentially responsible parties. At September 27, 2009, the Companys
condensed consolidated balance sheet included an accrued liability of approximately $8.5 million
relating to these matters. Considerable uncertainty exists with respect to these costs and, if
adverse changes in circumstances occur, potential liability may exceed the amount accrued as of
September 27, 2009. The time frame over which the accrued amounts may be paid out, based on past
history, is estimated to be 15-20 years.
Regulatory matters: On October 11, 2007, the Companys subsidiary, Arrow International,
Inc. (Arrow), received a corporate warning letter from the U.S. Food and Drug Administration
(FDA). The letter cites three site-specific warning letters issued by the FDA in 2005 and
subsequent inspections performed from June 2005 to February 2007 at Arrows facilities in the
United States. The letter expresses concerns with Arrows quality systems, including complaint
handling, corrective and preventive action, process and design validation, inspection and training
procedures. It also advises that Arrows corporate-wide program to evaluate, correct and prevent
quality system issues has been deficient. Limitations on pre-market approvals and certificates for
foreign governments had previously been imposed on Arrow based on prior inspections and the
corporate warning letter did not impose additional sanctions that are expected to have a material
financial impact on the Company.
In connection with its acquisition of Arrow, completed on October 1, 2007, the Company
developed an integration plan that included the commitment of significant resources to correct
these previously-identified regulatory issues and further improve overall quality systems. Senior
management officials from the Company have met with FDA representatives, and a comprehensive
written corrective action plan was presented to FDA in late 2007. The Company has completed
implementation of the corrective actions under the plan and is awaiting re-inspection by the FDA.
While the Company believes it has substantially remediated these issues through the corrective
actions taken to date, there can be no assurances that these issues have been resolved to the
satisfaction of the FDA. If the Companys remedial actions are not satisfactory to the FDA, the
Company may have to devote additional financial and human resources to its efforts, and the FDA may
take further regulatory actions against the Company, including, but not limited to, seizing its
product inventory, obtaining a court injunction against further marketing of the Companys
products, assessing civil monetary penalties or imposing a consent decree on us.
Litigation: The Company is a party to various lawsuits and claims arising in the normal
course of business. These lawsuits and claims include actions involving product liability,
intellectual property, employment and environmental matters. Based on information currently
available, advice of counsel, established reserves and other resources, the Company does not
believe that any such actions are likely to be, individually or in the aggregate, material to its
business, financial condition, results of operations or liquidity. However, in the event of
unexpected further developments, it is possible that the ultimate resolution of these matters, or
other similar matters, if unfavorable, may be materially adverse to the Companys business,
financial condition, results of operations or liquidity. Legal costs such as outside counsel fees
and expenses are charged to expense in the period incurred.
Other: The Company has various purchase commitments for materials, supplies and items of
permanent investment incident to the ordinary conduct of business. On average, such commitments are
not at prices in excess of current market.
20
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 15 Business segment information
Information about continuing operations by business segment is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Segment data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
355,876 |
|
|
$ |
367,327 |
|
|
$ |
1,060,346 |
|
|
$ |
1,125,719 |
|
Aerospace |
|
|
45,847 |
|
|
|
62,105 |
|
|
|
126,537 |
|
|
|
194,126 |
|
Commercial |
|
|
59,756 |
|
|
|
74,603 |
|
|
|
188,176 |
|
|
|
249,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net
revenues |
|
$ |
461,479 |
|
|
$ |
504,035 |
|
|
$ |
1,375,059 |
|
|
$ |
1,569,486 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
73,839 |
|
|
$ |
71,388 |
|
|
$ |
222,607 |
|
|
$ |
212,952 |
|
Aerospace |
|
|
4,554 |
|
|
|
7,309 |
|
|
|
8,611 |
|
|
|
19,894 |
|
Commercial
|
|
|
4,649 |
|
|
|
4,861 |
|
|
|
11,529 |
|
|
|
21,376 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating
profit(1)
|
|
|
83,042 |
|
|
|
83,558 |
|
|
|
242,747 |
|
|
|
254,222 |
|
Less: Corporate
expenses |
|
|
8,944 |
|
|
|
11,448 |
|
|
|
30,373 |
|
|
|
36,013 |
|
Net loss on sales of
businesses and
assets |
|
|
|
|
|
|
|
|
|
|
2,597 |
|
|
|
18 |
|
Goodwill
impairment |
|
|
|
|
|
|
|
|
|
|
6,728 |
|
|
|
|
|
Restructuring and other
impairment charges |
|
|
4,783 |
|
|
|
470 |
|
|
|
13,412 |
|
|
|
11,917 |
|
Noncontrolling
interest |
|
|
(305 |
) |
|
|
(196 |
) |
|
|
(843 |
) |
|
|
(642 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from
continuing
operations before
interest and
taxes
|
|
$ |
69,620 |
|
|
$ |
71,836 |
|
|
$ |
190,480 |
|
|
$ |
206,916 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 27, 2009 |
|
|
December 31, 2008 |
|
|
|
(Dollars in thousands) |
|
Identifiable assets(2): |
|
|
|
|
|
|
|
|
Medical |
|
$ |
3,173,803 |
|
|
$ |
3,135,360 |
|
Aerospace |
|
|
140,265 |
|
|
|
244,994 |
|
Commercial |
|
|
110,678 |
|
|
|
215,894 |
|
Corporate |
|
|
373,923 |
|
|
|
322,286 |
|
|
|
|
|
|
|
|
|
|
$ |
3,798,669 |
|
|
$ |
3,918,534 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Segment operating profit includes a segments net revenues reduced by its
materials, labor and other product costs along with the segments selling, engineering
and administrative expenses and non-controlling interest. Unallocated corporate expenses,
loss on sales of businesses and assets, goodwill impairment, restructuring and other
impairment charges, interest income and expense and taxes on income are excluded from the
measure. |
|
(2) |
|
Identifiable assets do not include assets held for sale of $9.0 million and $8.2
million in 2009 and 2008, respectively. |
Note 16 Divestiture-related activities
When dispositions occur in the normal course of business, gains or losses on the sale of such
businesses or assets are recognized in the income statement line item Net loss on sales of
businesses and assets.
The following table provides the amount of Net loss on sales of businesses and assets for the
three and nine month periods ended September 27, 2009 and September 28, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net loss on
sales of businesses
and assets |
|
$ |
|
|
|
$ |
|
|
|
$ |
2,597 |
|
|
$ |
18 |
|
21
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
During the first quarter of 2009, the Company realized a loss of $2.6 million on the sale of a
product line in its Marine business.
Assets Held for Sale
Assets held for sale at September 27, 2009 and December 31, 2008 consists of four buildings
which the Company is actively marketing. During the second quarter of 2009, the Company sold two
buildings at approximately net book value and added two new properties to assets held for sale.
Discontinued Operations
During the third quarter of 2009, the Company completed the sale of its Power Systems
operations to Fuel Systems Solutions, Inc. for $14.5 million and realized a loss of $3.3 million,
net of tax. During the second quarter, the Company recognized a non-cash goodwill impairment charge
of $25.1 million to adjust the carrying value of these operations to their estimated fair value.
In the third quarter of 2009, the Company reported the Power Systems operations, including the
goodwill impairment charge, in discontinued operations. Taxes on discontinued operations in the third quarter reflect: (1) a tax benefit resulting from tax versus book basis
differences on the sale of the Power Systems businesses; and (2) a tax benefit resulting from changes in forecasted
2009 pre-tax income as compared to actual 2009 year-to-date results of those discontinued businesses.
On March 20, 2009, the Company completed the sale of its 51 percent share of Airfoil
Technologies International Singapore Pte. Ltd. (ATI Singapore) to GE Pacific Private Limited
for $300 million in cash. ATI Singapore, which provides engine repair products and services for
critical components of flight turbines, was part of a joint venture between General Electric
Company (GE) and the Company. The Company and GE are also parties to an agreement that will
permit the Company to transfer its ownership interest in the remaining ATI business (together with
ATI Singapore, the ATI businesses) to GE by the end of 2009.
In the second quarter of 2008, the Company refined its estimates for the post-closing
adjustments based on the provisions of the Purchase Agreement with Kongsberg Automotive Holdings on
the sale in 2007 of the Companys business units that design and manufacture automotive and
industrial driver controls, motion systems and fluid handling systems (the GMS businesses). Also
during the second quarter of 2008, the Company recorded a charge for the settlement of a
contingency related to the sale of the GMS businesses. These activities resulted in a decrease in
the gain on sale of the GMS businesses and are reported in discontinued operations as a loss of
$4.8 million, with related taxes of $2.0 million.
The following table presents the operating results for the three and nine month periods ended
September 27, 2009 and September 28, 2008 of the operations that have been treated as discontinued
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net revenues |
|
$ |
4,214 |
|
|
$ |
91,847 |
|
|
$ |
111,089 |
|
|
$ |
255,001 |
|
Costs and other expenses |
|
|
4,941 |
|
|
|
69,545 |
|
|
|
114,174 |
|
|
|
202,343 |
|
Loss (gain) on disposition |
|
|
3,480 |
|
|
|
|
|
|
|
(272,307 |
) |
|
|
4,808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations before income taxes |
|
|
(4,207 |
) |
|
|
22,302 |
|
|
|
269,222 |
|
|
|
47,850 |
|
Taxes (benefit) on income from discontinued operations |
|
|
(7,785 |
) |
|
|
(17 |
) |
|
|
92,881 |
|
|
|
(233 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
3,578 |
|
|
|
22,319 |
|
|
|
176,341 |
|
|
|
48,083 |
|
Less: Income from discontinued operations attributable to
noncontrolling interest |
|
|
|
|
|
|
9,431 |
|
|
|
9,860 |
|
|
|
25,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations attributable to common
shareholders |
|
$ |
3,578 |
|
|
$ |
12,888 |
|
|
$ |
166,481 |
|
|
$ |
22,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets and liabilities sold in 2009 in relation to the discontinued operations were
comprised of the following:
|
|
|
|
|
|
|
(Dollars in thousands) |
|
Net assets |
|
$ |
135,904 |
|
Net liabilities |
|
|
(87,534 |
) |
|
|
|
|
|
|
$ |
48,370 |
|
|
|
|
|
22
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
All statements made in this Quarterly Report on Form 10-Q, other than statements of historical
fact, are forward-looking statements. The words anticipate, believe, estimate, expect,
intend, may, plan, will, would, should, guidance, potential, continue, project,
forecast, confident, prospects, and similar expressions typically are used to identify
forward-looking statements. Forward-looking statements are based on the then-current expectations,
beliefs, assumptions, estimates and forecasts about our business and the industry and markets in
which we operate. These statements are not guarantees of future performance and are subject to
risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and
results may differ materially from what is expressed or implied by these forward-looking statements
due to a number of factors, including our ability to resolve, to the satisfaction of the U.S. Food
and Drug Administration (FDA), the issues identified in the corporate warning letter issued to Arrow
International; changes in business relationships with and purchases by or from major customers or
suppliers, including delays or cancellations in shipments; demand for and market acceptance of new
and existing products; our ability to integrate acquired businesses into our operations, realize
planned synergies and operate such businesses profitably in accordance with expectations; our
ability to effectively execute our restructuring programs; competitive market conditions and
resulting effects on revenues and pricing; increases in raw material costs that cannot be recovered
in product pricing; and global economic factors, including currency exchange rates and interest
rates; difficulties entering new markets; and general economic conditions. For a further
discussion of the risks relating to our business, see Item 1A of our Annual Report on Form 10-K for
the fiscal year ended December 31, 2008. We expressly disclaim any obligation to update these
forward-looking statements, except as otherwise specifically stated by us or as required by law or
regulation.
Overview
Teleflex strives to maintain a portfolio of businesses that provide consistency of
performance, improved profitability and sustainable growth. Over the past several years, we
significantly changed the composition of our portfolio through acquisitions and divestitures to
improve margins, reduce cyclicality and focus our resources on the development of our core
businesses.
During the third quarter of 2009, we completed the sale of our Power Systems operations to
Fuel Systems Solutions, Inc. for $14.5 million and realized a loss of $3.3 million, net of tax.
During the second quarter, we recognized a non-cash goodwill impairment charge of $25.1 million to
adjust the carrying value of these operations to their estimated fair value. In the third quarter
of 2009, we reported the Power Systems operations, including the goodwill impairment charge, as
discontinued operations.
On March 20, 2009, we completed the sale of our 51 percent share of Airfoil Technologies
International Singapore Pte. Ltd. (ATI Singapore) to GE Pacific Private Limited for $300
million in cash. We recognized a gain of approximately $178 million, net of $98 million of taxes,
in discontinued operations. We used $240 million of the proceeds of this transaction to repay
long-term debt. We are also party to an agreement with General Electric Company (GE) that will
permit us to transfer our ownership interest in the remaining ATI business (together with ATI
Singapore, the ATI businesses) to GE by the end of 2009 for no additional consideration. (See
Note 16 to our condensed consolidated financial statements included in this report for discussion
of discontinued operations).
We are focused on achieving consistent and sustainable growth through our internal growth
initiatives which include the development of new products, expansion of market share, moving
existing products into new geographies, and through selected acquisitions which enhance or expedite
our development initiatives and our ability to increase market share. We continually evaluate the
composition of the portfolio of our businesses to ensure alignment with our overall objectives.
The Medical, Aerospace and Commercial segments comprised 77%, 9% and 14% of our revenues,
respectively, for the nine months ended September 27, 2009 and comprised 72%, 12% and 16% of our
revenues, respectively, for the same period in 2008.
Results of Operations
Discussion of growth from acquisitions reflects the impact of a purchased company for up to
twelve months beyond the date of acquisition. Activity beyond the initial twelve months is
considered core growth. Core growth excludes the impact of translating the results of international
subsidiaries at different currency exchange rates from year to year and the comparable activity of
divested companies within the most recent twelve-month period.
The following comparisons exclude the operations of the ATI businesses and Power Systems which
have been presented in our consolidated financial results as discontinued operations (see Note 16
to our condensed consolidated financial statements included in this report for discussion of
discontinued operations).
23
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
Net
revenues |
|
$ |
461.5 |
|
|
$ |
504.0 |
|
|
$ |
1,375.1 |
|
|
$ |
1,569.5 |
|
Net revenues for the third quarter of 2009 decreased approximately 8% to $461.5 million from
$504.0 million in the third quarter of 2008. Core revenues for the quarter declined 6%, and
foreign currency translation caused an additional 2% decline in revenue. Core revenues were down
in the Aerospace Segment (23%), as air cargo traffic continues to be well below 2008 levels and in
the Commercial Segment (16%), as weak global economic conditions continue to negatively impact the
markets served by our products in this segment. Core revenues in the Medical Segment were down 1%
from the third quarter of 2008 as higher sales of critical care products were offset by lower sales
of surgical products and orthopedic devices sold to medical original equipment manufacturers, or
OEMs.
Net revenues for the first nine months of 2009 decreased approximately 12% to $1,375.1 million
from $1,569.5 million in the first nine months of 2008. Reduced revenues from core business caused
8% of the decline, while foreign currency translation caused 4% of the decline. We experienced
declines in core revenue in each of our three segments, Medical (1%), Aerospace (29%) and
Commercial (21%). Weak global economic conditions have negatively impacted markets served by our
Aerospace and Commercial Segments throughout 2009, and core growth in the Medical Segment was
negatively impacted by distributor inventory reductions in the first quarter of 2009, lower demand
for respiratory care products in North America due to a less severe flu season compared to 2008 and
a decline in orthopedic devices sold to medical OEMs.
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
Gross
profit |
|
$ |
200.6 |
|
|
$ |
209.8 |
|
|
$ |
594.3 |
|
|
$ |
651.7 |
|
Percentage of
sales |
|
|
43.5 |
% |
|
|
41.6 |
% |
|
|
43.2 |
% |
|
|
41.5 |
% |
Gross profit as a percentage of revenues for third quarter of 2009 increased to 43.5% from
41.6% in 2008. While each of our three segments reported higher gross profit as a percentage of
revenues, the overall increase principally reflected a higher percentage of Medical revenues,
synergies from the Arrow acquisition and manufacturing cost reductions implemented in each of our
three segments.
Gross profit as a percentage of revenues for the first nine months of 2009 increased to 43.2%
from 41.5% for the same period in 2008. The principal factors impacting the overall increase were
a higher percentage of Medical revenues, a $7 million fair value adjustment to inventory in the
first quarter of 2008 related to inventory acquired in the Arrow acquisition, which did not recur
in 2009, synergies from the Arrow acquisition and manufacturing cost reductions implemented in each
of our three segments, partly offset by higher pension expense because of the decline in value of our pension plan assets at the end of 2008 as a result of losses experienced in the global equity markets. Gross profit as a percentage of revenue for the first nine months of 2009
was higher in the Medical and Aerospace segments, and lower in the Commercial Segment compared to
the same period of 2008.
Selling, engineering and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
Selling, engineering
and administrative |
|
$ |
126.2 |
|
|
$ |
137.5 |
|
|
$ |
381.1 |
|
|
$ |
432.8 |
|
Percentage of
sales |
|
|
27.3 |
% |
|
|
27.3 |
% |
|
|
27.7 |
% |
|
|
27.6 |
% |
Selling, engineering and administrative expenses (operating expenses) as a percentage of
revenues were 27.3% for the third quarter of 2009 and 2008. The reduction in the dollar amount of these costs was principally the result
of cost reduction initiatives throughout the Company, including restructuring and integration
activities in connection with the Arrow acquisition, and lower spending on remediation of FDA
regulatory issues.
24
Selling, engineering and administrative expenses as a percentage of revenues were 27.7% for
the first nine months of 2009 which is essentially the same percentage as in the first nine months
of 2008. The reduction in these costs was principally the result of movements in currency exchange
rates of approximately $12 million, cost reduction initiatives, including restructuring and
integration activities in connection with the Arrow acquisition and the 2008 Commercial Segment
restructuring program, and lower spending on remediation of FDA regulatory issues. These factors
resulted in an aggregate reduction in expenses of approximately $40 million.
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions ) |
|
Interest expense |
|
$ |
21.1 |
|
|
$ |
29.0 |
|
|
$ |
68.5 |
|
|
$ |
91.4 |
|
Average interest
rate on debt |
|
|
5.8 |
% |
|
|
6.2 |
% |
|
|
5.8 |
% |
|
|
6.3 |
% |
Interest expense decreased in the third quarter of 2009 compared to the same period of 2008
due to a reduction of approximately $315 million in average outstanding debt during the period and
lower interest rates. For the first nine months of 2009 average outstanding debt was approximately
$275 million lower than in the corresponding period of 2008.
Taxes on income from continuing operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income
tax rate |
|
|
28.2 |
% |
|
|
31.6 |
% |
|
|
23.6 |
% |
|
|
33.6 |
% |
The principal factors affecting the comparability of the effective income tax rate for the
three month period are the beneficial net impact of discrete tax charges in the third quarter of
2009, including a net reduction in income tax reserves related to the expiration of statutes of
limitation for various uncertain tax positions, the settlement of tax audits, and adjustments to
previously filed tax returns, partially offset by the impact of 2009 foreign income inclusions that
will be immediately taxed in the U.S. The principal factors affecting the comparability of the
effective income tax rate for the nine month period are the beneficial net impact of discrete tax
charges in 2009, including a net reduction in income tax reserves related to the expiration of
statutes of limitation for various uncertain tax positions, the settlement of tax audits, and
adjustments to previously filed tax returns, partially offset by the impact of 2009 foreign income
inclusions that will be immediately taxed in the U.S. and the impairment loss of $6.7 million on
non-deductible goodwill for which there is no income tax benefit.
Goodwill impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
Goodwill impairment |
|
$ |
|
|
|
$ |
|
|
|
$ |
6.7 |
|
|
$ |
|
|
We performed an interim review of goodwill for our Cargo Container reporting unit during the
second quarter of 2009 as a result of the difficult market conditions confronting the Cargo
Container reporting unit and the significant deterioration in its operating performance, which
accelerated in the second quarter of 2009. Upon conclusion of this review, we determined that
goodwill in the Cargo Container operations was impaired, and we recorded an impairment charge of
$6.7 million in the second quarter of 2009.
We will continue to monitor and evaluate the carrying values of our goodwill. If market and
economic conditions or our units business performance deteriorates significantly, this could
result in our performance of additional interim impairment reviews in the future quarters. Any such
impairment reviews could result in recognition of a goodwill impairment charge in 2009 or
thereafter.
25
Restructuring and other impairment charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 27, |
|
|
September 28, |
|
|
September 27, |
|
|
September 28, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
2008
Commercial Segment Restructuring Program |
|
$ |
0.2 |
|
|
$ |
|
|
|
$ |
2.2 |
|
|
$ |
|
|
2007 Arrow
Integration Program |
|
|
1.3 |
|
|
|
0.4 |
|
|
|
5.4 |
|
|
|
11.2 |
|
2006
Restructuring Program |
|
|
|
|
|
|
0.1 |
|
|
|
|
|
|
|
0.7 |
|
Impairment
charges - intangibles and fixed assets |
|
|
3.3 |
|
|
|
|
|
|
|
5.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other impairment
charges |
|
$ |
4.8 |
|
|
$ |
0.5 |
|
|
$ |
13.4 |
|
|
$ |
11.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In December 2008, we began certain restructuring initiatives that affect the Commercial
Segment. These initiatives involve the consolidation of operations and a related reduction in
workforce at three of our facilities in Europe and North America. We determined to undertake these
initiatives to improve operating performance and to better leverage our existing resources in light
of expected continued weakness in the marine and industrial markets. These initiatives resulted in
costs of approximately $0.2 million and $2.2 million during the three and nine months ended
September 27, 2009, respectively. As of September 27, 2009, we have completed the 2008 Commercial
Segment restructuring program. We expect to realize annual pre-tax savings of between $3.5 $4.5
million in 2010 as a result of actions taken in connection with this program.
In connection with the acquisition of Arrow in 2007, we formulated a plan related to the
integration of Arrow and our other Medical businesses. The integration plan focuses on the closure
of Arrow corporate functions and the consolidation of manufacturing, sales, marketing and
distribution functions in North America, Europe and Asia. During the third quarter of 2009 we
reassessed the plan and decided to retain certain functions in Europe and maintain certain
distributor relationships in Asia. Costs related to actions that affect employees and facilities of
Arrow have been included in the allocation of the purchase price of Arrow. Costs related to actions
that affect employees and facilities of Teleflex are charged to earnings and included in
restructuring and impairment charges within the condensed consolidated statement of operations.
These costs amounted to approximately $1.3 million and $5.4 million during the three and nine
months ended September 27, 2009, respectively. As of September 27, 2009, we estimate that, for the
remainder of 2009 and for 2010, the aggregate of future restructuring and impairment charges that
we will incur in connection with the Arrow integration plan are approximately $2.9 $4.7 million.
Of this amount, $1.5 $2.5 million relates to employee termination costs, $0.2 $0.4 million
relates to facility closure costs, $0.5 $0.8 million relates to contract termination costs
associated with the termination of leases and certain distribution agreements and $0.7 $1.0
million relates to other restructuring costs. We also have incurred restructuring related costs in
the Medical Segment which do not qualify for classification as restructuring costs. In 2009 these
costs amounted to $1.8 million and are reported in the Medical Segments operating results in
selling, engineering and administrative expenses. We expect to have realized annual pre-tax savings
of between $70 $75 million in 2010 after these integration and restructuring actions are
complete.
For additional information regarding our restructuring programs, see Note 4 to our condensed
consolidated financial statements included in this report.
During the second quarter of 2009, we recorded a $2.3 million impairment charge related to an
intangible asset in the Commercial Segment. In 2004, we contributed
property and other assets that had been part of one of our former
manufacturing sites to a real estate venture
in California. During the third quarter of 2009, based on continued deterioration in the California real
estate market, we concluded that our investment was not recoverable
and recorded $3.3 million in impairment charges to fully write-off our investment in this venture. See Note 5 to our condensed consolidated financial
statements included in this report for further information.
26
Segment Reviews
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
September 27, |
|
|
September 28, |
|
|
Increase/ |
|
|
September 27, |
|
|
September 28, |
|
|
Increase/ |
|
|
|
2009 |
|
|
2008 |
|
|
(Decrease) |
|
|
2009 |
|
|
2008 |
|
|
(Decrease) |
|
|
|
(Dollars in millions) |
|
Medical |
|
$ |
355.9 |
|
|
$ |
367.3 |
|
|
|
(3 |
) |
|
$ |
1,060.3 |
|
|
$ |
1,125.7 |
|
|
|
(6 |
) |
Aerospace |
|
|
45.8 |
|
|
|
62.1 |
|
|
|
(26 |
) |
|
|
126.6 |
|
|
|
194.1 |
|
|
|
(35 |
) |
Commercial |
|
|
59.8 |
|
|
|
74.6 |
|
|
|
(20 |
) |
|
|
188.2 |
|
|
|
249.7 |
|
|
|
(25 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net revenues |
|
$ |
461.5 |
|
|
$ |
504.0 |
|
|
|
(8 |
) |
|
$ |
1,375.1 |
|
|
$ |
1,569.5 |
|
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
73.8 |
|
|
$ |
71.4 |
|
|
|
3 |
|
|
$ |
222.6 |
|
|
$ |
213.0 |
|
|
|
5 |
|
Aerospace |
|
|
4.6 |
|
|
|
7.3 |
|
|
|
(38 |
) |
|
|
8.6 |
|
|
|
19.9 |
|
|
|
(57 |
) |
Commercial |
|
|
4.6 |
|
|
|
4.9 |
|
|
|
(4 |
) |
|
|
11.5 |
|
|
|
21.3 |
|
|
|
(46 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating
profit
(1) |
|
$ |
83.0 |
|
|
$ |
83.6 |
|
|
|
(1 |
) |
|
$ |
242.7 |
|
|
$ |
254.2 |
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 15 of our condensed consolidated financial statements for a reconciliation of
segment operating profit to income from continuing operations before interest and taxes. |
The percentage decreases in net revenues during the three and nine month periods ended
September 27, 2009 compared to the same period in 2008 are due to the following factors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Decrease |
|
|
|
2009 vs. 2008 |
|
|
|
Medical |
|
|
Aerospace |
|
|
Commercial |
|
|
Total |
|
|
|
Three |
|
|
Nine |
|
|
Three |
|
|
Nine |
|
|
Three |
|
|
Nine |
|
|
Three |
|
|
Nine |
|
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
Core growth |
|
|
1 |
|
|
|
1 |
|
|
|
23 |
|
|
|
29 |
|
|
|
16 |
|
|
|
21 |
|
|
|
6 |
|
|
|
8 |
|
Currency impact |
|
|
2 |
|
|
|
5 |
|
|
|
3 |
|
|
|
6 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
4 |
|
Dispositions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total change |
|
|
3 |
|
|
|
6 |
|
|
|
26 |
|
|
|
35 |
|
|
|
20 |
|
|
|
25 |
|
|
|
8 |
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following is a discussion of our segment operating results.
Comparison of the three and nine month periods ended September 27, 2009 and September 28, 2008
Medical
Medical Segment net revenues declined 3% in the third quarter of 2009 to $355.9 million, from
$367.3 million in the same period last year. Foreign currency fluctuations caused 2% of the revenue
decline and core revenues declined 1% compared to the third quarter of 2008. Core revenue
increases in the North American, European and Asia/Latin American critical care product groups were
offset by declines in OEM orthopedic instrumentation products and in North American and European
surgical products.
Net revenues for the first nine months of 2009 declined 6% to $1,060.3 million compared to
$1,125.7 million in the same period of 2008. Foreign currency fluctuations caused 5% of this
decrease while core revenue declined 1% during the first nine months compared to the same period in
2008. The decline in core revenue was predominantly in the North American critical care market in
the first quarter of 2009, in cardiac care in the first quarter of 2009 due to a voluntary product
recall and in the OEM orthopedic instrumentation product group for the nine month period.
27
Information regarding net sales by product group is provided in the following tables. Certain
reclassifications within product groups have been made to 2008 amounts to conform to the current
year presentation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
% Increase/(Decrease) |
|
|
|
September 27, |
|
|
September 28, |
|
|
Core |
|
|
Currency |
|
|
Total |
|
|
|
2009 |
|
|
2008 |
|
|
Growth |
|
|
Impact |
|
|
Change |
|
|
|
(Dollars in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Critical Care |
|
$ |
231.6 |
|
|
$ |
230.4 |
|
|
|
3 |
|
|
|
(2 |
) |
|
|
1 |
|
Surgical |
|
|
66.7 |
|
|
|
75.8 |
|
|
|
(10 |
) |
|
|
(2 |
) |
|
|
(12 |
) |
Cardiac Care |
|
|
16.9 |
|
|
|
17.3 |
|
|
|
1 |
|
|
|
(3 |
) |
|
|
(2 |
) |
OEM |
|
|
37.6 |
|
|
|
39.4 |
|
|
|
(4 |
) |
|
|
(1 |
) |
|
|
(5 |
) |
Other |
|
|
3.1 |
|
|
|
4.4 |
|
|
|
(24 |
) |
|
|
(6 |
) |
|
|
(30 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
355.9 |
|
|
$ |
367.3 |
|
|
|
(1 |
) |
|
|
(2 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
% Increase/(Decrease) |
|
|
|
September 27, |
|
|
September 28, |
|
|
Core |
|
|
Currency |
|
|
Total |
|
|
|
2009 |
|
|
2008 |
|
|
Growth |
|
|
Impact |
|
|
Change |
|
|
|
(Dollars in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Critical Care |
|
$ |
680.7 |
|
|
$ |
720.4 |
|
|
|
(1 |
) |
|
|
(5 |
) |
|
|
(6 |
) |
Surgical |
|
|
208.8 |
|
|
|
223.1 |
|
|
|
(1 |
) |
|
|
(5 |
) |
|
|
(6 |
) |
Cardiac Care |
|
|
51.6 |
|
|
|
54.5 |
|
|
|
(1 |
) |
|
|
(4 |
) |
|
|
(5 |
) |
OEM |
|
|
109.4 |
|
|
|
116.5 |
|
|
|
(5 |
) |
|
|
(1 |
) |
|
|
(6 |
) |
Other |
|
|
9.8 |
|
|
|
11.2 |
|
|
|
(3 |
) |
|
|
(9 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
1,060.3 |
|
|
$ |
1,125.7 |
|
|
|
(1 |
) |
|
|
(5 |
) |
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Segment net revenues for the nine months ended September 27, 2009 and September 28,
2008, respectively, by geographic location were as follows:
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
North America |
|
|
54 |
% |
|
|
53 |
% |
Europe, Middle East and Africa |
|
|
35 |
% |
|
|
37 |
% |
Asia and Latin America |
|
|
11 |
% |
|
|
10 |
% |
All of our critical care product categories (vascular, anesthesia, respiratory and
urology) contributed growth in the quarter compared with the prior year, led principally
by higher sales of vascular products in North America, Europe and Asia/Latin America
and urology and respiratory care products in North America and Europe. For the first
nine months of 2009, the 1% decline in core revenue was due principally to distributor
inventory reductions in the first quarter of 2009 and, with regard to our respiratory care
products, a less severe flu season in the first quarter of 2009 compared to 2008.
Surgical core revenue declined approximately 10% in the third quarter of 2009 compared with
2008. The decline resulted from declines in both the North American and European markets offset by
growth in the Asia/Latin American markets. Principal reasons for the decline included a distributor
re-stock of surgical products at the end of the second quarter of 2009 and a $3 million order in
the second quarter of 2008 that did not recur in 2009, as well as the re-stocking by customers in
the third quarter of 2008 after a product recall earlier in 2008. For the first nine months of
2009, surgical product core revenue decreased 1% as higher sales in Asia/Latin America were more
than offset by declines in North America and Europe.
Sales credits issued to customers and the related delay in shipments of replacement products
in connection with a voluntary recall of certain intra aortic balloon pump catheters during the
first quarter of 2009 were the principal factors in the lack of growth in sales of cardiac care
products during the first nine months of 2009 compared to the same period of 2008.
Core revenue to OEMs declined 4% in the third quarter of 2009 and 5% for the first nine months
of 2009. These declines were largely attributable to lower sales of orthopedic instrumentation
products due to customer inventory rebalancing, a reduction in new product launches by OEM
customers and overall weakness in the OEM orthopedic markets.
28
Operating profit in the Medical Segment increased 3%, from $71.4 million in the third quarter
of 2008 to $73.8 million during the third quarter of 2009. The negative impact on operating profit
from slightly lower revenues and a stronger US dollar was largely
offset by approximately $13 million lower manufacturing and selling, general and
administrative costs during the current period as a result of cost reduction initiatives, including
restructuring and integration activities in connection with the Arrow acquisition, and lower
expenses related to the remediation of FDA regulatory issues.
Medical Segment operating profit increased 5% from $213.0 million during the first nine months
of 2008 to $222.6 million during the first nine months of 2009. The negative impact on operating
profit from slightly lower revenues and a stronger US dollar was largely offset by approximately
$32 million of lower manufacturing and selling, general and administrative costs during the 2009
period as a result of cost reduction initiatives, including restructuring and integration
activities in connection with the Arrow acquisition, and lower expenses related to the remediation
of FDA regulatory issues. Also, a $7 million expense for fair value adjustment to inventory in the
first quarter and year to date 2008 related to inventory acquired in the Arrow acquisition, which
did not recur in 2009, had a favorable impact on the comparison of first quarter of 2009 operating
profit to the prior year period.
Aerospace
Aerospace Segment revenues declined 26% in the third quarter of 2009 to $45.8 million, from
$62.1 million in the same period last year and declined 35% for the first nine months of 2009 to
$126.6 million, from $194.1 million in the same period of 2008. The current weakness in the
commercial aviation sector has resulted in reduced sales to commercial airlines and freight
carriers of wide body cargo spare components and repairs, cargo containers and actuators. This
market weakness has also reduced the number of aftermarket cargo system conversions, resulting in
lower sales of multi-deck wide body cargo handling systems which has offset the impact of higher
sales of single deck wide body systems on passenger aircraft. These conditions were the principal
factors driving the 23% and 29% decline in core revenue during the quarter and for the first nine
months, respectively.
Segment operating profit decreased 38% in the third quarter of 2009, from $7.3 million to $4.6
million, and decreased 57% for the first nine months of 2009, from $19.9 million to $8.6 million.
This decline was principally due to the sharply lower sales volumes across the product lines noted
above, including an unfavorable mix of lower margin systems sales compared with spares and repairs.
The decrease was partially offset by cost reduction initiatives that resulted in operating cost
reductions of approximately $4 million in the third quarter of 2009 and approximately $8 million
for the first nine months of 2009 compared to the same periods of 2008.
Commercial
Commercial Segment revenues declined approximately 20% in the third quarter of 2009 to $59.8
million, from $74.6 million in the same period last year. Core revenue reductions accounted for 16%
of the decline, which was principally a result of a decrease in demand for rigging services (14%),
and a decline in sales of marine products to OEM manufacturers for the
recreational boat market (11%), offset by increased sales of spare parts in the Marine aftermarket
(4%). Weakness in global economic conditions continues to adversely impact the markets served by
our Commercial businesses.
Commercial Segment revenues declined approximately 25% in the first nine months of 2009 to
$188.2 million, from $249.7 million in the same period last year. Core revenue reductions accounted
for 21% of the decline, which was principally a result of a decline in sales of marine products to
OEM manufacturers for the recreational boat market (18%) with an offset from sales of the modern
burner unit to the U.S. Military.
During the third quarter of 2009, operating profit in the Commercial Segment decreased 4%,
from $4.9 million in the third quarter of 2008 to $4.6 million, principally due to the lower sales
volumes of rigging services, and the sale of higher cost inventory in the rigging services
business, which more than offset the impact from the elimination of approximately $3 million of
operating costs compared to the corresponding prior year quarter.
For the first nine months of 2009, Commercial Segment operating income decreased 46%, from
$21.3 million in the first nine months of 2008 to $11.5 million, principally due to the lower sales
volumes of rigging products and marine products to OEM manufacturers for the recreational boat
market and the sale of higher cost inventory in the rigging services business, which more than
offset the impact from the elimination of approximately $7 million of operating costs compared to
the corresponding prior year period.
29
Liquidity and Capital Resources
Operating activities from continuing operations provided net cash of approximately $81.2
million during the first nine months of 2009. Changes in our operating assets and liabilities,
which reduced cash by $115.7 million during the first nine months of 2009, primarily reflect
payment of income taxes and decreases in accounts payable and accrued expenses partly offset by a
reduction in accounts receivable and inventory. The movement in income taxes payable and deferred
income taxes of $92.4 million during the first nine months of 2009 reflects tax payments of
approximately $124.3 million which included approximately $97.5 million related to the sale of the
ATI businesses. The decrease in accounts payable and accrued expenses of $45.5 million is primarily related
to a $32.7 million reduction in accounts payable and a $12.8
million decrease in accrued expenses reflecting payment of 2008 incentive compensation and
payments for termination
benefits and contract terminations in connection with restructuring and integration activities. The improvement in inventory of $7.5 million reflects an
increase in deliveries of wide body cargo systems in the Aerospace Segment during the third quarter
of 2009 and the sale of a product line in the
Marine business in the first quarter of 2009, partly offset by the build-up of inventory that
occurred during the first half of 2009 in advance of planned manufacturing relocations in the
Medical Segment. The change in accounts receivable is largely attributable to lower sales in the
Aerospace and Commercial Segments, partly offset by a slightly slower paying pattern from our
European customers in our Medical Segment. We believe the slower paying pattern is a result of the
current economic environment.
Our financing activities from continuing operations during the first nine months of 2009
consisted primarily of payment of $300.3 million in long-term borrowings, which we funded from the
proceeds of the sale of the ATI and Power Systems businesses, and payment of dividends of $40.5
million. Cash flows provided by our investing activities from continuing operations during the
first nine months of 2009 consisted primarily of the proceeds from the sales of the ATI and Power Systems businesses, offset principally by $21.5 million of capital expenditures.
The interests in receivables sold and the interest in receivables retained by the special
purpose entity (SPE) under our accounts receivable securitization program are carried at face
value, which is due to the short-term nature of our accounts receivable. The special purpose entity
has received cash consideration of $39.7 million and $39.7 million for the interests in the
accounts receivable it has sold to the commercial paper conduit at September 27, 2009 and December
31, 2008, respectively. No gain or loss is recorded upon sale as fee charges from the commercial
paper conduit are based upon a floating yield rate and the period the undivided interests remain
outstanding. Fee charges from the commercial paper conduit are accrued at the end of each month.
Should we default under the accounts receivable securitization program, the commercial paper
conduit is entitled to receive collections on receivables owned by the SPE in satisfaction of the
amount of cash consideration paid to the SPE by the commercial paper conduit.
In the first quarter of 2010, we will adopt an amendment to ASC topic 860, Transfers
and Servicing that affects the accounting for transfers of financial assets. The accounts
receivable that we had previously treated as sold and removed from the balance sheet will
be included in accounts receivable, net and the amounts outstanding
under our accounts
receivable securitization program will be accounted for as a secured borrowing and
reflected as short-term debt on our balance sheet (which as of September 27, 2009 is $39.7 million for both).
On June 14, 2007, our Board of Directors authorized the repurchase of up to $300 million of
our outstanding common stock. Repurchases of our stock under the Board authorization may be made
from time to time in the open market and may include privately-negotiated transactions as market
conditions warrant and subject to regulatory considerations. The stock repurchase program has no
expiration date, and our ability to execute on the program will depend on, among other factors,
cash requirements for acquisitions, cash generation from operations, debt repayment obligations,
market conditions and regulatory requirements. In addition, our senior loan agreements impose
certain restrictions on our ability to repurchase shares in the event our consolidated leverage
ratio (described below) exceeds certain levels, which may further limit our ability to repurchase
shares under this Board authorization. Through September 27, 2009, no shares have been purchased
under this Board authorization.
The following table provides our net debt to total capital ratio:
|
|
|
|
|
|
|
|
|
|
|
September 27, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in millions) |
|
Net debt includes: |
|
|
|
|
|
|
|
|
Current
borrowings |
|
$ |
6.0 |
|
|
$ |
108.9 |
|
Long-term
borrowings |
|
|
1,248.6 |
|
|
|
1,437.5 |
|
|
|
|
|
|
|
|
Total
debt |
|
|
1,254.6 |
|
|
|
1,546.4 |
|
Less: Cash and cash
equivalents |
|
|
158.8 |
|
|
|
107.3 |
|
|
|
|
|
|
|
|
Net
debt |
|
$ |
1,095.8 |
|
|
$ |
1,439.1 |
|
|
|
|
|
|
|
|
Total capital includes: |
|
|
|
|
|
|
|
|
Net
debt |
|
$ |
1,095.8 |
|
|
$ |
1,439.1 |
|
Total common shareholders
equity |
|
|
1,549.1 |
|
|
|
1,246.5 |
|
|
|
|
|
|
|
|
Total
capital |
|
$ |
2,644.9 |
|
|
$ |
2,685.6 |
|
|
|
|
|
|
|
|
|
Percent of net debt to total
capital |
|
|
41 |
% |
|
|
54 |
% |
30
Our current borrowings decreased significantly during the first nine months of 2009 because we
repaid $300.3 million of debt from the proceeds of the sales of the ATI and Power Systems
businesses and improved operating cash flows in the third quarter of 2009.
Of the $300.3 million payment $203 million represented scheduled principal payments on our
term loan through December 31, 2010.
Our senior credit agreement and senior note agreements, which we refer to as the senior loan
agreements, contain covenants that, among other things, limit or restrict our ability, and the
ability of our subsidiaries, to incur debt, create liens, consolidate, merge or dispose of certain
assets, make certain investments, engage in acquisitions, pay dividends on, repurchase or make
distributions in respect of capital stock and enter into swap agreements. These agreements also
require us to maintain a Consolidated Leverage Ratio (generally, Consolidated Total Indebtedness to
Consolidated EBITDA, each as defined in the senior credit agreement) and a Consolidated Interest
Coverage Ratio (generally, Consolidated EBITDA to Consolidated Interest Expense, each as defined in
the senior credit agreement) at specified levels as of the last day of any period of four
consecutive fiscal quarters ending on or nearest to the end of each calendar quarter, calculated
pursuant to the definitions and methodology set forth in the senior credit agreement. The
following table indicates the applicable ratios under the senior loan agreements and provides
actual ratios for prior periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Leverage |
|
|
Consolidated Interest |
|
|
|
Ratio |
|
|
Coverage Ratio |
|
Fiscal quarter ending on or |
|
Must be |
|
|
|
|
|
|
Must be |
|
|
|
|
nearest to |
|
less than |
|
|
Actual |
|
|
more than |
|
|
Actual |
|
|
December 31, 2007 |
|
|
4.75:1 |
|
|
|
3.80:1 |
|
|
|
3.00:1 |
|
|
|
3.46:1 |
|
March 31, 2008 |
|
|
4.75:1 |
|
|
|
3.84:1 |
|
|
|
3.00:1 |
|
|
|
3.51:1 |
|
June 30, 2008 |
|
|
4.75:1 |
|
|
|
3.71:1 |
|
|
|
3.00:1 |
|
|
|
3.58:1 |
|
September 30, 2008 |
|
|
4.75:1 |
|
|
|
3.43:1 |
|
|
|
3.00:1 |
|
|
|
3.78:1 |
|
December 31, 2008 |
|
|
4.00:1 |
|
|
|
3.29:1 |
|
|
|
3.50:1 |
|
|
|
4.04:1 |
|
March 31, 2009 |
|
|
4.00:1 |
|
|
|
3.13:1 |
|
|
|
3.50:1 |
|
|
|
4.16:1 |
|
June 30, 2009 |
|
|
4.00:1 |
|
|
|
3.19:1 |
|
|
|
3.50:1 |
|
|
|
4.37:1 |
|
September 30, 2009 and at all times
thereafter |
|
|
3.50:1 |
|
|
|
3.14:1 |
|
|
|
3.50:1 |
|
|
|
4.52:1 |
|
As of September 27, 2009, the aggregate amount of debt maturing for each year is as follows
(dollars in millions):
|
|
|
|
|
2009 |
|
$ |
6.0 |
|
2010 |
|
|
0.1 |
|
2011 |
|
|
247.2 |
|
2012 |
|
|
769.7 |
|
2013 |
|
|
|
|
2014 and thereafter |
|
|
231.6 |
|
We believe that our cash flow from operations and our ability to access additional funds
through credit facilities will enable us to fund our operating requirements and capital
expenditures and meet debt obligations. As of September 27, 2009, we had no outstanding borrowings
and approximately $7 million in outstanding standby letters of credit issued under our $400 million
revolving credit facility.
Potential Tax Legislation
President Obama and the U.S. Treasury Department proposed, on May 5, 2009, changing certain
tax rules for U.S. corporations doing business outside the United States. The proposed changes
would limit the ability of U.S. corporations to deduct expenses attributable to foreign earnings,
modify the foreign tax credit rules and further restrict the ability of U.S. corporations to
transfer funds between foreign subsidiaries without triggering U.S. income tax. It is unclear
whether these proposed tax reforms will be enacted or, if enacted, what the ultimate scope of the
reforms will be. Depending on their content, such reforms, if enacted, could have an adverse effect
on our future operating results.
31
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no significant changes in market risk for the quarter ended September 27,
2009. See the information set forth in Part II, Item 7A of the Companys Annual Report on Form
10-K for the fiscal year ended December 31, 2008.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial
Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of
the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that our disclosure controls and procedures as of the end of the period
covered by this report are functioning effectively to provide reasonable assurance that the
information required to be disclosed by us in reports filed under the Securities Exchange Act of
1934 is (i) recorded, processed, summarized and reported within the time periods specified in the
SECs rules and forms and (ii) accumulated and communicated to our management, including the Chief
Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding
disclosure. A controls system cannot provide absolute assurance that the objectives of the
controls system are met, and no evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, within a company have been detected.
(b) Change in Internal Control over Financial Reporting
No change in our internal control over financial reporting occurred during our most recent
fiscal quarter that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.
32
PART II OTHER INFORMATION
Item 1. Legal Proceedings
On October 11, 2007, the Companys subsidiary, Arrow International, Inc. (Arrow), received a
corporate warning letter from the U.S. Food and Drug Administration (FDA). The letter cites three
site-specific warning letters issued by the FDA in 2005 and subsequent inspections performed from
June 2005 to February 2007 at Arrows facilities in the United States. The letter expresses
concerns with Arrows quality systems, including complaint handling, corrective and preventive
action, process and design validation, inspection and training procedures. It also advises that
Arrows corporate-wide program to evaluate, correct and prevent quality system issues has been
deficient. Limitations on pre-market approvals and certificates for foreign governments had
previously been imposed on Arrow based on prior inspections and the corporate warning letter did
not impose additional sanctions that are expected to have a material financial impact on the
Company.
In connection with its acquisition of Arrow, completed on October 1, 2007, the Company
developed an integration plan that included the commitment of significant resources to correct
these previously-identified regulatory issues and further improve overall quality systems. Senior
management officials from the Company have met with FDA representatives, and a comprehensive
written corrective action plan was presented to FDA in late 2007. The Company has completed
implementation of the corrective actions under the plan and is awaiting re-inspection by the FDA.
While the Company believes it has substantially remediated these issues through the corrective
actions taken to date, there can be no assurances that these issues have been resolved to the
satisfaction of the FDA. If the Companys remedial actions are not satisfactory to the FDA, the
Company may have to devote additional financial and human resources to its efforts, and the FDA may
take further regulatory actions against the Company, including, but not limited to, seizing its
product inventory, obtaining a court injunction against further marketing of the Companys
products, assessing civil monetary penalties or imposing a consent decree on us.
In addition, we are a party to various lawsuits and claims arising in the normal course of
business. These lawsuits and claims include actions involving product liability, intellectual
property, employment and environmental matters. Based on information currently available, advice
of counsel, established reserves and other resources, we do not believe that any such actions are
likely to be, individually or in the aggregate, material to our business, financial condition,
results of operations or liquidity. However, in the event of unexpected further developments, it is
possible that the ultimate resolution of these matters, or other similar matters, if unfavorable,
may be materially adverse to our business, financial condition, results of operations or liquidity.
Item 1A. Risk Factors
There have been no significant changes in risk factors for the quarter ended September 27,
2009. See the information set forth in Part I, Item 1A of the Companys Annual Report on Form 10-K
for the fiscal year ended December 31, 2008.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders
Not applicable.
Item 5. Other Information
Not applicable.
33
Item 6. Exhibits
The following exhibits are filed as part of this report:
|
|
|
|
|
|
|
Exhibit No. |
|
|
|
Description |
|
|
|
|
|
|
|
|
31.1 |
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
31.2 |
|
|
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
32.1 |
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
32.2 |
|
|
|
|
Certification of Chief Financial Officer, Pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
34
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
TELEFLEX INCORPORATED
|
|
|
By: |
/s/ Jeffrey P. Black
|
|
|
|
Jeffrey P. Black |
|
|
|
Chairman and Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
|
|
By: |
/s/ Kevin K. Gordon
|
|
|
|
Kevin K. Gordon |
|
|
|
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer) |
|
|
|
|
|
|
By: |
/s/ Charles E. Williams
|
|
|
|
Charles E. Williams |
|
|
|
Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer) |
|
|
Dated: October 27, 2009
35
EXHIBIT INDEX
|
|
|
|
|
|
|
Exhibit No. |
|
|
|
Description |
|
|
|
|
|
|
|
|
31.1 |
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
31.2 |
|
|
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
32.1 |
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
|
|
|
|
|
|
|
|
32.2 |
|
|
|
|
Certification of Chief Financial Officer, Pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
36